(674135, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674136, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674137, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674138, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003471', 'abnormal summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674139, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0014255', 'increased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674140, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674141, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674142, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674143, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674144, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674145, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674146, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674147, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674148, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674149, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674150, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674151, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674152, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674153, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674154, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674155, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674156, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674157, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674158, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674159, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674160, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674161, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674162, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674163, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674164, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674165, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674166, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674167, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674168, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674169, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674170, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674171, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674172, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674173, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674174, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674175, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674176, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001898', 'abnormal long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674177, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674178, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674179, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002195', 'psychomotor seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674180, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0021010', 'impaired synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674181, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674182, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674183, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674184, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674185, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005402', 'abnormal action potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674186, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674187, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674188, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003490', 'decreased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674189, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011994', 'increased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674190, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003475', 'increased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674191, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674192, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674193, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674194, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674195, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674196, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674197, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674198, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674199, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674200, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002635', 'reduced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674201, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674202, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674203, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674204, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674205, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674206, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003468', 'increased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674207, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674208, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674209, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674210, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002207', 'abnormal long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674211, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003088', 'abnormal prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674212, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006058', 'decreased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674213, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674214, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674215, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674216, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674217, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674218, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674219, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674220, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674221, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674222, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674223, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674224, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674225, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010050', 'hypermyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674226, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674227, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0014252', 'abnormal paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674228, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674229, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674230, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0013806', 'encephalopathy', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674231, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674232, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004994', 'abnormal brain wave pattern', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674233, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003464', 'abnormal single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674234, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003633', 'abnormal nervous system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674235, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674236, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674237, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674238, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003484', 'abnormal channel response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674239, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674240, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674241, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674242, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674243, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674244, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674245, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674246, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0021015', 'increased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674247, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674248, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674249, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674250, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674251, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674252, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0030990', 'nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674253, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674254, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674255, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674256, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674257, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674258, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003487', 'increased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674259, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674260, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674261, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674262, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674263, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012006', 'abnormal hippocampus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674264, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674265, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674266, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674267, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674268, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674269, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674270, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674271, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674272, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674273, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674274, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674275, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003467', 'abnormal single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674276, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674277, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674278, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000947', 'convulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674279, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674280, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674281, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674282, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674283, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674284, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002578', 'impaired ability to fire action potentials', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674285, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674286, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674287, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674288, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674289, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674290, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674291, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674292, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674293, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674294, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674295, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674296, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674297, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006080', 'brain ischemia', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674298, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674299, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674300, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674301, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674302, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0014253', 'decreased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674303, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674304, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674305, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674306, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674307, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008921', 'increased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674308, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674309, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674310, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674311, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674312, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674313, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001900', 'impaired synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674314, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0013438', 'dysmyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674315, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674316, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674317, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674318, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674319, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674320, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674321, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674322, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674323, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674324, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674325, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674326, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674327, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674328, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674329, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674330, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674331, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674332, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674333, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674334, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001500', 'decreased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674335, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674336, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674337, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674338, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674339, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674340, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003474', 'abnormal summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674341, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674342, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000951', 'sporadic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674343, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674344, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674345, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674346, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674347, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674348, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674349, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003997', 'tonic-clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674350, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0009358', 'environmentally induced seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674351, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674352, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674353, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001473', 'reduced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674354, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001496', 'audiogenic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674355, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674356, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674357, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674358, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002193', 'minimal clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674359, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674360, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674361, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674362, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674363, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674364, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674365, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674366, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674367, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004859', 'abnormal synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674368, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674369, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674370, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674371, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0004811', 'abnormal neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674372, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674373, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674374, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(674375, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0021009', 'abnormal synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674376, 'HP:0012662', 'Parietal hypometabolism in FDG PET', 'MP:0000948', 'nonconvulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674377, 'HP:0003758', 'Reduced subcutaneous adipose tissue', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.4117647058823529, 7.4735768925632104, 1.7542392057685403, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674378, 'HP:0003758', 'Reduced subcutaneous adipose tissue', 'MP:0002060', 'abnormal skin morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674379, 'HP:0002070', 'Limb ataxia', 'MP:0001405', 'impaired coordination', 0.425531914893617, 13.548253578857707, 2.4010860644457583, 'UPHENO:0080275', 'decreased motor coordination'),
(674380, 'HP:0002070', 'Limb ataxia', 'MP:0020351', 'decreased vocalization', 0.4186046511627907, 10.749166272783702, 2.121238081383006, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(674381, 'HP:0002070', 'Limb ataxia', 'MP:0001442', 'decreased grooming behavior', 0.4186046511627907, 10.749166272783702, 2.121238081383006, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(674382, 'HP:0002070', 'Limb ataxia', 'MP:0009747', 'impaired behavioral response to xenobiotic', 0.4090909090909091, 10.749166272783702, 2.096994564251997, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(674383, 'HP:0002070', 'Limb ataxia', 'MP:0003158', 'dysphagia', 0.43137254901960786, 10.749166272783702, 2.1533451314005156, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(674384, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674385, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674386, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0013806', 'encephalopathy', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674387, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0006080', 'brain ischemia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674388, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674389, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674390, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0003470', 'abnormal summary potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674391, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674392, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674393, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674394, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674395, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674396, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674397, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674398, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674399, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674400, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674401, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674402, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674403, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674404, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674405, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674406, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674407, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674408, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674409, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0005402', 'abnormal action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674410, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674411, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0003463', 'abnormal single cell response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674412, 'HP:0032921', 'Focal impaired awareness pedal automatism seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674413, 'HP:0008345', 'Hypoplasia of the iris dilator muscle', 'MP:0006226', 'iris hypoplasia', 0.46153846153846156, 15.192109768632433, 2.647969593884727, 'UPHENO:0081251', 'iris hypoplasia'),
(674414, 'HP:0008345', 'Hypoplasia of the iris dilator muscle', 'MP:0006230', 'iris stroma hypoplasia', 0.43902439024390244, 15.192109768632433, 2.5825775356593437, 'UPHENO:0081251', 'iris hypoplasia'),
(674415, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0020403', 'lysinuria', 0.4024390243902439, 10.47786425096631, 2.0534608510639534, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674416, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0011516', 'aspartylglucosaminuria', 0.4383561643835616, 10.47786425096631, 2.143137042744871, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674417, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0020401', 'argininuria', 0.4125, 10.47786425096631, 2.0789706596110498, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674418, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0002931', 'glutaricadicuria', 0.49295774647887325, 12.732678149995134, 2.5053287862997924, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(674419, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0020406', 'hyperthreoninuria', 0.4125, 10.47786425096631, 2.0789706596110498, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674420, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0003311', 'aminoaciduria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674421, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0030689', 'cystathioninuria', 0.4074074074074074, 10.47786425096631, 2.066097652496837, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674422, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0030613', 'dicarboxylic aciduria', 0.5483870967741935, 12.732678149995134, 2.6424300189098746, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(674423, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0030620', 'valinuria', 0.4024390243902439, 10.47786425096631, 2.0534608510639534, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674424, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0011654', 'histidinuria', 0.42857142857142855, 10.47786425096631, 2.119083115503998, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674425, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0030617', 'hyperglutaminuria', 0.4125, 10.47786425096631, 2.0789706596110498, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674426, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0020405', 'taurinuria', 0.4125, 10.47786425096631, 2.0789706596110498, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674427, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.4074074074074074, 10.47786425096631, 2.066097652496837, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674428, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0020400', 'cystinuria', 0.42857142857142855, 10.47786425096631, 2.119083115503998, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674429, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0011765', 'oroticaciduria', 0.5, 10.47786425096631, 2.2888713649926147, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674430, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0020402', 'ornithinuria', 0.4074074074074074, 10.47786425096631, 2.066097652496837, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674431, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0011517', 'hyperoxaluria', 0.4927536231884058, 12.732678149995134, 2.504810030980783, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(674432, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0020404', 'prolinuria', 0.4125, 10.47786425096631, 2.0789706596110498, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674433, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0030618', 'tryptophanuria', 0.42857142857142855, 10.47786425096631, 2.119083115503998, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(674434, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0030615', 'ethylmalonic aciduria', 0.49295774647887325, 12.732678149995134, 2.5053287862997924, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(674435, 'HP:0410153', 'Increased level of methylsuccinic acid in urine', 'MP:0030614', 'methylmalonic aciduria', 0.5, 12.732678149995134, 2.5231605329422795, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(674436, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674437, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012222', 'decreased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674438, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020255', 'absent circulating factor XII protein', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674439, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674440, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0002941', 'increased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674441, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031082', 'decreased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674442, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011886', 'increased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674443, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674444, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012621', 'decreased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674445, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674446, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0001570', 'abnormal circulating enzyme level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674447, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020256', 'abnormal circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674448, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674449, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674450, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005308', 'abnormal circulating ammonia level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674451, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012622', 'increased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674452, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674453, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005419', 'decreased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674454, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031108', 'increased circulating myoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674455, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674456, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674457, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674458, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674459, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0001560', 'abnormal circulating insulin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674460, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011889', 'abnormal circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674461, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674462, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674463, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674464, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012619', 'increased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674465, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011887', 'decreased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674466, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031078', 'increased circulating troponin T level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674467, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674468, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005416', 'abnormal circulating protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674469, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674470, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0013255', 'abnormal circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674471, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674472, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674473, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0004730', 'abnormal circulating gastrin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674474, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031059', 'increased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674475, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674476, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674477, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020258', 'decreased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674478, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011885', 'abnormal circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674479, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010091', 'decreased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674480, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674481, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674482, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674483, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031077', 'increased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674484, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674485, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674486, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020257', 'increased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674487, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020248', 'decreased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674488, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674489, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674490, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674491, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012331', 'increased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674492, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674493, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674494, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674495, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674496, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012328', 'decreased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674497, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674498, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674499, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0013403', 'abnormal circulating lactate level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(674500, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674501, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674502, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020247', 'increased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674503, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674504, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674505, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674506, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011891', 'decreased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674507, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0013257', 'decreased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674508, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674509, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005567', 'decreased circulating total protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674510, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674511, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011893', 'increased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674512, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0008804', 'abnormal circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674513, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674514, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674515, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0013256', 'increased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674516, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674517, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674518, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674519, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010210', 'abnormal circulating cytokine level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674520, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674521, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674522, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011890', 'increased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674523, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0002695', 'abnormal circulating glucagon level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674524, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674525, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674526, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674527, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0008806', 'increased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674528, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012616', 'increased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674529, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674530, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674531, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031083', 'increased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674532, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0003349', 'abnormal circulating renin level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674533, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010090', 'increased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674534, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674535, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674536, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674537, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031076', 'decreased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674538, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674539, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674540, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0002965', 'increased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674541, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0008805', 'decreased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674542, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020984', 'decreased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674543, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674544, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020246', 'abnormal circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674545, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674546, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674547, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674548, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674549, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674550, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012615', 'decreased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674551, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674552, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674553, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012617', 'abnormal circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674554, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012333', 'increased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674555, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674556, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674557, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674558, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0005667', 'abnormal circulating leptin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674559, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674560, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674561, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674562, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(674563, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674564, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674565, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674566, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012618', 'decreased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674567, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0031079', 'increased circulating troponin I level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674568, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674569, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674570, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0010215', 'abnormal circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674571, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0011894', 'decreased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674572, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020985', 'increased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674573, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674574, 'HP:0045046', 'Reduced insulin like growth factor binding protein acid labile subunit concentration', 'MP:0012330', 'decreased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(674575, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000852', 'small cerebellum', 0.46808510638297873, 9.732678149995134, 2.134413663569404, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674576, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000912', 'small trigeminal motor nucleus', 0.40384615384615385, 9.35921975446769, 1.9441411730743015, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(674577, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012139', 'increased forebrain size', 0.4117647058823529, 6.72807461644252, 1.664446954875396, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674578, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020534', 'increased pons size', 0.46, 9.35921975446769, 2.074907488794413, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(674579, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000866', 'cerebellum vermis hypoplasia', 0.4074074074074074, 9.732678149995134, 1.9912722496485105, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674580, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012262', 'abnormal hindbrain size', 0.4666666666666667, 10.879226813348076, 2.2532138187255484, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(674581, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012447', 'thick cerebellar granule layer', 0.4444444444444444, 9.732678149995134, 2.0798160335306513, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674582, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020526', 'enlarged thalamus', 0.4117647058823529, 6.72807461644252, 1.664446954875396, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674583, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012137', 'abnormal forebrain size', 0.40425531914893614, 6.72807461644252, 1.649199791210218, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674584, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020563', 'increased pontine nuclei size', 0.4423076923076923, 9.35921975446769, 2.034614187358176, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(674585, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012091', 'increased midbrain size', 0.40384615384615385, 6.72807461644252, 1.6483649646362448, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674586, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012483', 'increased corticospinal tract size', 0.4222222222222222, 5.9605885577567275, 1.5864088207673317, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(674587, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000831', 'diencephalon hyperplasia', 0.4375, 6.72807461644252, 1.7156726507972324, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674588, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020540', 'decreased cerebellum fastigial nucleus size', 0.41509433962264153, 9.732678149995134, 2.009970051874391, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674589, 'HP:0012081', 'Enlarged cerebellum', 'MP:0008914', 'enlarged cerebellum', 0.5681818181818182, 15.87018167374507, 3.002856752871213, 'UPHENO:0001084', 'increased size of the cerebellum'),
(674590, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000887', 'delaminated cerebellar granule layer', 0.40384615384615385, 9.732678149995134, 1.9825500340465647, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674591, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012676', 'dilated brain ventricle', 0.4117647058823529, 6.72807461644252, 1.664446954875396, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674592, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020533', 'decreased pons size', 0.40384615384615385, 9.35921975446769, 1.9441411730743015, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(674593, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020538', 'abnormal cerebellum fastigial nucleus size', 0.4489795918367347, 9.732678149995134, 2.0904004074012046, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674594, 'HP:0012081', 'Enlarged cerebellum', 'MP:0005238', 'increased brain size', 0.45454545454545453, 6.213399309526074, 1.6805571735055438, 'UPHENO:0076805', 'abnormal brain morphology'),
(674595, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012487', 'increased cerebellum dentate nucleus size', 0.4897959183673469, 9.732678149995134, 2.183352017575425, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674596, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012485', 'increased cochlear VIII nucleus size', 0.45098039215686275, 9.35921975446769, 2.0544645519336893, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(674597, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012467', 'increased striatum size', 0.40384615384615385, 6.72807461644252, 1.6483649646362448, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674598, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000851', 'cerebellum hypoplasia', 0.41509433962264153, 9.732678149995134, 2.009970051874391, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674599, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012263', 'decreased hindbrain size', 0.42857142857142855, 10.879226813348076, 2.1592882570766636, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(674600, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000910', 'small facial motor nucleus', 0.40384615384615385, 9.35921975446769, 1.9441411730743015, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(674601, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000884', 'delaminated Purkinje cell layer', 0.40384615384615385, 9.732678149995134, 1.9825500340465647, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674602, 'HP:0012081', 'Enlarged cerebellum', 'MP:0011380', 'enlarged brain ventricles', 0.4375, 6.72807461644252, 1.7156726507972324, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674603, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012472', 'decreased cerebellum interpositus nucleus size', 0.43137254901960786, 9.732678149995134, 2.0490022406895614, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674604, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020532', 'abnormal pons size', 0.4375, 9.35921975446769, 2.023526289075488, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(674605, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012266', 'hindbrain hyperplasia', 0.46, 10.879226813348076, 2.2370615400878258, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(674606, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012488', 'decreased cerebellum dentate nucleus size', 0.43137254901960786, 9.732678149995134, 2.0490022406895614, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674607, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012265', 'increased hindbrain size', 0.48936170212765956, 10.879226813348076, 2.307352801635001, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(674608, 'HP:0012081', 'Enlarged cerebellum', 'MP:0012471', 'increased cerebellum interpositus nucleus size', 0.4897959183673469, 9.732678149995134, 2.183352017575425, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674609, 'HP:0012081', 'Enlarged cerebellum', 'MP:0000771', 'abnormal brain size', 0.42857142857142855, 6.213399309526074, 1.6318349850301401, 'UPHENO:0076805', 'abnormal brain morphology'),
(674610, 'HP:0012081', 'Enlarged cerebellum', 'MP:0008534', 'enlarged fourth ventricle', 0.41509433962264153, 8.423925443855504, 1.8699528788575308, 'UPHENO:0086932', 'abnormal hindbrain morphology'),
(674611, 'HP:0012081', 'Enlarged cerebellum', 'MP:0002809', 'increased spinal cord size', 0.4418604651162791, 5.9605885577567275, 1.6228827537740238, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(674612, 'HP:0012081', 'Enlarged cerebellum', 'MP:0013229', 'abnormal brain ventricle size', 0.41304347826086957, 6.72807461644252, 1.6670294963119532, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(674613, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020539', 'increased cerebellum fastigial nucleus size', 0.47058823529411764, 9.732678149995134, 2.1401130426432684, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(674614, 'HP:0012081', 'Enlarged cerebellum', 'MP:0020561', 'abnormal pontine nuclei size', 0.42, 9.35921975446769, 1.982642755737006, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(674615, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0010385', 'abnormal glycinergic neuron morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674616, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0020849', 'abnormal actin cytoskeleton morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674617, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0020325', 'abnormal beige fat cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674618, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002632', 'vestigial tail', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(674619, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0006361', 'abnormal female germ cell morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674620, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0009587', 'abnormal plasma membrane sphingolipid content', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(674621, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003903', 'increased cell mass', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(674622, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002882', 'abnormal neuron morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674623, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004986', 'abnormal osteoblast morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674624, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013206', 'abnormal motile cilium morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674625, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674626, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004698', 'abnormal thyroid parafollicular C-cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674627, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002883', 'chromatolysis', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674628, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674629, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0000952', 'abnormal CNS glial cell morphology', 0.41379310344827586, 4.8755453832354885, 1.420375673944019, 'UPHENO:0086172', 'abnormal cell'),
(674630, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013202', 'abnormal cilium morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(674631, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0012360', 'abnormal large unstained cell number', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(674632, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008886', 'abnormal PML bodies', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674633, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0009115', 'abnormal fat cell morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674634, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0031094', 'organomegaly', 0.42857142857142855, 3.008048030199787, 1.1354133350961642, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(674635, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0000358', 'abnormal cell morphology', 0.6086956521739131, 6.121988824155609, 1.930395809133662, 'UPHENO:0084928', 'abnormal cell morphology'),
(674636, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0005075', 'abnormal melanosome morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674637, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003199', 'calcified muscle', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(674638, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0030908', 'abnormal melanocyte differentiation', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674639, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0020851', 'abnormal vacuole morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674640, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0012203', 'abnormal neuronal stem cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674641, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0030953', 'abnormal Golgi cisterna morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674642, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013203', 'abnormal primary cilium morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674643, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002163', 'abnormal gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674644, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002400', 'abnormal multipotent stem cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674645, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008888', 'abnormal Cajal body morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674646, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0000313', 'abnormal cell death', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674647, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003186', 'abnormal redox activity', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674648, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013658', 'abnormal myeloid cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674649, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002582', 'disorganized extraembryonic tissue', 0.42857142857142855, 3.008048030199787, 1.1354133350961642, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(674650, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002877', 'abnormal melanocyte morphology', 0.5384615384615384, 6.121988824155609, 1.8156143645331664, 'UPHENO:0084928', 'abnormal cell morphology'),
(674651, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0009841', 'foam cell reticulosis', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(674652, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003902', 'abnormal cell mass', 0.5384615384615384, 6.121988824155609, 1.8156143645331664, 'UPHENO:0084928', 'abnormal cell morphology'),
(674653, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003702', 'abnormal chromosome morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674654, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0005499', 'abnormal olfactory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674655, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002429', 'abnormal blood cell morphology/development', 0.42857142857142855, 4.8755453832354885, 1.445517018218072, 'UPHENO:0086172', 'abnormal cell'),
(674656, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003630', 'abnormal urothelium morphology', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674657, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(674658, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011975', 'neuronal cytoplasmic inclusions', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674659, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0006378', 'abnormal spermatogonia morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674660, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0020850', 'abnormal microtubule cytoskeleton morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674661, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013205', 'abnormal nonmotile primary cilium morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674662, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0009536', 'abnormal interstitial cell of Cajal morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674663, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003449', 'abnormal intestinal goblet cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674664, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003877', 'abnormal serotonergic neuron morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674665, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004101', 'abnormal brain interneuron morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674666, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0001124', 'abnormal gametes', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674667, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0001026', 'abnormal adrenergic neuron morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674668, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003077', 'abnormal cell cycle', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674669, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008199', 'increased follicular dendritic cell number', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674670, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0001105', 'abnormal PNS glial cell morphology', 0.41379310344827586, 4.8755453832354885, 1.420375673944019, 'UPHENO:0086172', 'abnormal cell'),
(674671, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0020846', 'abnormal cell motility', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674672, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002208', 'abnormal germ cell morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674673, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674674, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0014239', 'abnormal intracellular organelle morphology', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(674675, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011180', 'abnormal hematopoietic cell number', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674676, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0005500', 'abnormal gustatory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674677, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0030952', 'abnormal Golgi stack morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674678, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013707', 'abnormal hematopoietic precursor cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674679, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004150', 'absent caveolae', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(674680, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0020378', 'abnormal cell cytoskeleton morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674681, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008887', 'abnormal splicing factor domain morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674682, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008415', 'abnormal neurite morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674683, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011634', 'abnormal mitochondrial inner membrane morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674684, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0005058', 'abnormal lysosome morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674685, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004191', 'neuronal intranuclear inclusions', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674686, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0005623', 'abnormal meninges morphology', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674687, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0012736', 'abnormal polar body morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674688, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0020550', 'multinucleated giant male germ cells', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674689, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003956', 'abnormal body size', 0.4444444444444444, 3.008048030199787, 1.1562483451423184, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(674690, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0000716', 'abnormal immune system cell morphology', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(674691, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008890', 'abnormal nuclear lamina morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674692, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003719', 'abnormal pericyte morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674693, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0014238', 'abnormal ribosome morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674694, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003566', 'abnormal cell adhesion', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674695, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004141', 'abnormal enteroendocrine cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674696, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0014010', 'abnormal peroxisome morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674697, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003950', 'abnormal plasma membrane morphology', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(674698, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0001032', 'abnormal peptidergic neuron morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674699, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674700, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004808', 'abnormal hematopoietic stem cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674701, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013657', 'abnormal blood cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674702, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003247', 'abnormal glutaminergic neuron morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674703, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0012023', 'decreased melanocyte number', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(674704, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008889', 'abnormal Gem morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674705, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011633', 'abnormal mitochondrial shape', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674706, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011999', 'abnormal tail length', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(674707, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003245', 'abnormal GABAergic neuron morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674708, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004090', 'abnormal sarcomere morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674709, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003111', 'abnormal cell nucleus morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674710, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0000350', 'abnormal cell proliferation', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674711, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0000013', 'abnormal adipose tissue distribution', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(674712, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0009117', 'abnormal white fat cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674713, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0009116', 'abnormal brown fat cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674714, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(674715, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0010037', 'ectopic melanocytes', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674716, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674717, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0004087', 'abnormal muscle fiber morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(674718, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0012022', 'increased melanocyte number', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(674719, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0005621', 'abnormal cell physiology', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(674720, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0020581', 'abnormal neuron polarity', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674721, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0006362', 'abnormal male germ cell morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674722, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0012021', 'abnormal melanocyte number', 0.5185185185185185, 6.121988824155609, 1.7816746547807467, 'UPHENO:0084928', 'abnormal cell morphology'),
(674723, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003243', 'abnormal dopaminergic neuron morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674724, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003634', 'abnormal glial cell morphology', 0.42857142857142855, 4.8755453832354885, 1.445517018218072, 'UPHENO:0086172', 'abnormal cell'),
(674725, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0030942', 'abnormal microtubule organizing center morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674726, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003904', 'decreased cell mass', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674727, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0009378', 'abnormal endoplasmic reticulum morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674728, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0001038', 'abnormal cholinergic neuron morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(674729, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0006035', 'abnormal mitochondrial morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(674730, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674731, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0001577', 'anemia', 0.41379310344827586, 4.8755453832354885, 1.420375673944019, 'UPHENO:0086172', 'abnormal cell'),
(674732, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011743', 'abnormal Golgi apparatus morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674733, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008830', 'abnormal nucleolus morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(674734, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0009840', 'abnormal foam cell morphology', 0.56, 6.121988824155609, 1.851570614782796, 'UPHENO:0084928', 'abnormal cell morphology'),
(674735, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002183', 'gliosis', 0.41379310344827586, 4.8755453832354885, 1.420375673944019, 'UPHENO:0086172', 'abnormal cell'),
(674736, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003385', 'abnormal body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674737, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011113', 'abnormal airway basal cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674738, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002111', 'abnormal tail morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674739, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0000166', 'abnormal chondrocyte morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674740, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0008196', 'abnormal follicular dendritic cell morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(674741, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0014134', 'abnormal embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674742, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011637', 'abnormal mitochondrial matrix morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(674743, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0005076', 'abnormal cell differentiation', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(674744, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0003257', 'abnormal abdominal wall morphology', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674745, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674746, 'HP:0031929', 'Perivascular pseudorosette', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674747, 'HP:0005548', 'Megakaryocytopenia', 'MP:0008255', 'decreased megakaryocyte cell number', 0.4722222222222222, 16.19210976863243, 2.765189696460219, 'UPHENO:0085259', 'abnormally decreased number of megakaryocyte'),
(674748, 'HP:0005548', 'Megakaryocytopenia', 'MP:0008253', 'absent megakaryocytes', 0.4533333333333333, 16.19210976863243, 2.7093215193316147, 'UPHENO:0085259', 'abnormally decreased number of megakaryocyte'),
(674749, 'HP:0005548', 'Megakaryocytopenia', 'MP:0013662', 'decreased myeloid cell number', 0.4067796610169492, 11.533898285880637, 2.166045990955524, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(674750, 'HP:0025140', 'Decreased serum estrone', 'MP:0011611', 'abnormal circulating ghrelin level', 0.40425531914893614, 10.169741955603977, 2.027602594179888, 'UPHENO:0076293', 'abnormal hormone blood level'),
(674751, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0031112', 'rhabdomyolysis', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674752, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674753, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0009407', 'increased skeletal muscle fiber density', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674754, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000731', 'increased collagen deposition in the muscles', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674755, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674756, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674757, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674758, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0003632', 'abnormal nervous system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674759, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674760, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674761, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000767', 'abnormal smooth muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674762, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674763, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674764, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674765, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674766, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674767, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674768, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674769, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674770, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674771, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0003199', 'calcified muscle', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674772, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0010630', 'abnormal cardiac muscle tissue morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674773, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0004818', 'increased skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674774, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674775, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674776, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0005503', 'abnormal tendon morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674777, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674778, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674779, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674780, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674781, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000752', 'dystrophic muscle', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674782, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674783, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674784, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674785, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674786, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0004817', 'abnormal skeletal muscle mass', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674787, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674788, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000736', 'delayed muscle development', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674789, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674790, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000733', 'abnormal muscle development', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674791, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0004819', 'decreased skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674792, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0003939', 'abnormal myotome morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674793, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674794, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674795, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674796, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000749', 'muscle degeneration', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674797, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674798, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0004233', 'abnormal muscle weight', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674799, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674800, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674801, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0003397', 'increased muscle weight', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674802, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0005508', 'abnormal skeleton morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674803, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002108', 'abnormal muscle morphology', 0.5454545454545454, 7.206267831629091, 1.9825971715214765, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674804, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674805, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674806, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674807, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674808, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674809, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674810, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0012413', 'decreased muscle tumor incidence', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674811, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0010290', 'increased muscle tumor incidence', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(674812, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674813, 'HP:0001469', 'Abnormal morphology of the pelvis musculature', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674814, 'HP:0010648', 'Dermal translucency', 'MP:0031309', 'skin cyst', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674815, 'HP:0010648', 'Dermal translucency', 'MP:0010285', 'decreased skin tumor incidence', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674816, 'HP:0010648', 'Dermal translucency', 'MP:0009607', 'decreased keratohyalin granule size', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674817, 'HP:0010648', 'Dermal translucency', 'MP:0011239', 'abnormal skin coloration', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674818, 'HP:0010648', 'Dermal translucency', 'MP:0001208', 'blistering', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674819, 'HP:0010648', 'Dermal translucency', 'MP:0000574', 'abnormal foot pad morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674820, 'HP:0010648', 'Dermal translucency', 'MP:0001243', 'abnormal dermal layer morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674821, 'HP:0010648', 'Dermal translucency', 'MP:0002013', 'increased pilomatricoma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674822, 'HP:0010648', 'Dermal translucency', 'MP:0003853', 'dry skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674823, 'HP:0010648', 'Dermal translucency', 'MP:0009932', 'skin fibrosis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674824, 'HP:0010648', 'Dermal translucency', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674825, 'HP:0010648', 'Dermal translucency', 'MP:0000397', 'abnormal guard hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(674826, 'HP:0010648', 'Dermal translucency', 'MP:0000377', 'abnormal hair follicle morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674827, 'HP:0010648', 'Dermal translucency', 'MP:0008856', 'fetal bleb', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674828, 'HP:0010648', 'Dermal translucency', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674829, 'HP:0010648', 'Dermal translucency', 'MP:0001210', 'skin ridges', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674830, 'HP:0010648', 'Dermal translucency', 'MP:0008854', 'bleb', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674831, 'HP:0010648', 'Dermal translucency', 'MP:0003940', 'abnormal dermatome morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674832, 'HP:0010648', 'Dermal translucency', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674833, 'HP:0010648', 'Dermal translucency', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674834, 'HP:0010648', 'Dermal translucency', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674835, 'HP:0010648', 'Dermal translucency', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674836, 'HP:0010648', 'Dermal translucency', 'MP:0009931', 'abnormal skin appearance', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674837, 'HP:0010648', 'Dermal translucency', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674838, 'HP:0010648', 'Dermal translucency', 'MP:0003652', 'abnormal skin turgor', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674839, 'HP:0010648', 'Dermal translucency', 'MP:0005501', 'abnormal skin physiology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(674840, 'HP:0010648', 'Dermal translucency', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674841, 'HP:0010648', 'Dermal translucency', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674842, 'HP:0010648', 'Dermal translucency', 'MP:0001189', 'absent skin pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674843, 'HP:0010648', 'Dermal translucency', 'MP:0001213', 'abnormal skin cell number', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674844, 'HP:0010648', 'Dermal translucency', 'MP:0003196', 'calcified skin', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674845, 'HP:0010648', 'Dermal translucency', 'MP:0001191', 'abnormal skin condition', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674846, 'HP:0010648', 'Dermal translucency', 'MP:0009604', 'increased keratohyalin granule number', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674847, 'HP:0010648', 'Dermal translucency', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674848, 'HP:0010648', 'Dermal translucency', 'MP:0002897', 'blotchy skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674849, 'HP:0010648', 'Dermal translucency', 'MP:0009603', 'absent keratohyalin granules', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674850, 'HP:0010648', 'Dermal translucency', 'MP:0009441', 'delayed skin barrier formation', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674851, 'HP:0010648', 'Dermal translucency', 'MP:0000405', 'abnormal auchene hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(674852, 'HP:0010648', 'Dermal translucency', 'MP:0008816', 'petechiae', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674853, 'HP:0010648', 'Dermal translucency', 'MP:0013488', 'increased keratoacanthoma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674854, 'HP:0010648', 'Dermal translucency', 'MP:0001211', 'wrinkled skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674855, 'HP:0010648', 'Dermal translucency', 'MP:0002060', 'abnormal skin morphology', 0.5652173913043478, 7.4735768925632104, 2.055284806280393, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674856, 'HP:0010648', 'Dermal translucency', 'MP:0005421', 'loose skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674857, 'HP:0010648', 'Dermal translucency', 'MP:0011160', 'dermal-epidermal separation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674858, 'HP:0010648', 'Dermal translucency', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674859, 'HP:0010648', 'Dermal translucency', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674860, 'HP:0010648', 'Dermal translucency', 'MP:0001192', 'scaly skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674861, 'HP:0010648', 'Dermal translucency', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674862, 'HP:0010648', 'Dermal translucency', 'MP:0000367', 'abnormal coat/ hair morphology', 0.4444444444444444, 6.904974582545727, 1.7518212215413265, 'UPHENO:0003811', 'abnormal skin of body'),
(674863, 'HP:0010648', 'Dermal translucency', 'MP:0003705', 'abnormal hypodermis morphology', 0.44, 6.509554027552121, 1.692395867438506, 'UPHENO:0002635', 'abnormal integument'),
(674864, 'HP:0010648', 'Dermal translucency', 'MP:0001202', 'skin photosensitivity', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674865, 'HP:0010648', 'Dermal translucency', 'MP:0001197', 'oily skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674866, 'HP:0010648', 'Dermal translucency', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674867, 'HP:0010648', 'Dermal translucency', 'MP:0002095', 'abnormal skin pigmentation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674868, 'HP:0010648', 'Dermal translucency', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674869, 'HP:0010648', 'Dermal translucency', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674870, 'HP:0010648', 'Dermal translucency', 'MP:0012248', 'absent dermatome', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674871, 'HP:0010648', 'Dermal translucency', 'MP:0002108', 'abnormal muscle morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674872, 'HP:0010648', 'Dermal translucency', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674873, 'HP:0010648', 'Dermal translucency', 'MP:0005653', 'phototoxicity', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674874, 'HP:0010648', 'Dermal translucency', 'MP:0013406', 'abnormal epidermal immune compartment', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674875, 'HP:0010648', 'Dermal translucency', 'MP:0010700', 'hair follicle comedo', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674876, 'HP:0010648', 'Dermal translucency', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674877, 'HP:0010648', 'Dermal translucency', 'MP:0009827', 'skin detachment', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674878, 'HP:0010648', 'Dermal translucency', 'MP:0001216', 'abnormal epidermal layer morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674879, 'HP:0010648', 'Dermal translucency', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674880, 'HP:0010648', 'Dermal translucency', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674881, 'HP:0010648', 'Dermal translucency', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674882, 'HP:0010648', 'Dermal translucency', 'MP:0003941', 'abnormal skin development', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674883, 'HP:0010648', 'Dermal translucency', 'MP:0010300', 'increased skin tumor incidence', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674884, 'HP:0010648', 'Dermal translucency', 'MP:0010206', 'pigment incontinence', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674885, 'HP:0010648', 'Dermal translucency', 'MP:0005174', 'abnormal tail pigmentation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674886, 'HP:0010648', 'Dermal translucency', 'MP:0002015', 'epithelioid cyst', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674887, 'HP:0010648', 'Dermal translucency', 'MP:0010232', 'delayed skin pigmentation appearance', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674888, 'HP:0010648', 'Dermal translucency', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674889, 'HP:0010648', 'Dermal translucency', 'MP:0000400', 'abnormal awl hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(674890, 'HP:0010648', 'Dermal translucency', 'MP:0010016', 'variable depigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674891, 'HP:0010648', 'Dermal translucency', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674892, 'HP:0010648', 'Dermal translucency', 'MP:0001230', 'epidermal desquamation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674893, 'HP:0010648', 'Dermal translucency', 'MP:0031103', 'skin rash', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674894, 'HP:0010648', 'Dermal translucency', 'MP:0004241', 'acantholysis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674895, 'HP:0010648', 'Dermal translucency', 'MP:0001195', 'flaky skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674896, 'HP:0010648', 'Dermal translucency', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674897, 'HP:0010648', 'Dermal translucency', 'MP:0009606', 'increased keratohyalin granule size', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674898, 'HP:0010648', 'Dermal translucency', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674899, 'HP:0010648', 'Dermal translucency', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674900, 'HP:0010648', 'Dermal translucency', 'MP:0001193', 'psoriasis', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674901, 'HP:0010648', 'Dermal translucency', 'MP:0001196', 'shiny skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674902, 'HP:0010648', 'Dermal translucency', 'MP:0002732', 'increased trichoepithelioma incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674903, 'HP:0010648', 'Dermal translucency', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674904, 'HP:0010648', 'Dermal translucency', 'MP:0030584', 'skin atrophy', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674905, 'HP:0010648', 'Dermal translucency', 'MP:0009473', 'abnormal skin exfoliation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(674906, 'HP:0010648', 'Dermal translucency', 'MP:0010071', 'abnormal pruritus', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(674907, 'HP:0010648', 'Dermal translucency', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674908, 'HP:0010648', 'Dermal translucency', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674909, 'HP:0010648', 'Dermal translucency', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674910, 'HP:0010648', 'Dermal translucency', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674911, 'HP:0010648', 'Dermal translucency', 'MP:0005275', 'abnormal skin tensile strength', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(674912, 'HP:0010648', 'Dermal translucency', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674913, 'HP:0010648', 'Dermal translucency', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674914, 'HP:0010648', 'Dermal translucency', 'MP:0000407', 'abnormal duvet hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(674915, 'HP:0010648', 'Dermal translucency', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674916, 'HP:0010648', 'Dermal translucency', 'MP:0003632', 'abnormal nervous system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674917, 'HP:0010648', 'Dermal translucency', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674918, 'HP:0010648', 'Dermal translucency', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674919, 'HP:0010648', 'Dermal translucency', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674920, 'HP:0010648', 'Dermal translucency', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674921, 'HP:0010648', 'Dermal translucency', 'MP:0009605', 'decreased keratohyalin granule number', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674922, 'HP:0010648', 'Dermal translucency', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674923, 'HP:0010648', 'Dermal translucency', 'MP:0000383', 'abnormal hair follicle orientation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674924, 'HP:0010648', 'Dermal translucency', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674925, 'HP:0010648', 'Dermal translucency', 'MP:0012078', 'abnormal tail ring morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674926, 'HP:0010648', 'Dermal translucency', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674927, 'HP:0010648', 'Dermal translucency', 'MP:0001209', 'spontaneous skin ulceration', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674928, 'HP:0010648', 'Dermal translucency', 'MP:0009563', 'dyskeratosis', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674929, 'HP:0010648', 'Dermal translucency', 'MP:0001212', 'skin lesions', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674930, 'HP:0010648', 'Dermal translucency', 'MP:0009379', 'abnormal foot pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674931, 'HP:0010648', 'Dermal translucency', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674932, 'HP:0010648', 'Dermal translucency', 'MP:0001510', 'abnormal coat appearance', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(674933, 'HP:0010648', 'Dermal translucency', 'MP:0030923', 'abnormal hair follicle ostium morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674934, 'HP:0010648', 'Dermal translucency', 'MP:0009387', 'abnormal epidermal pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674935, 'HP:0010648', 'Dermal translucency', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674936, 'HP:0010648', 'Dermal translucency', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674937, 'HP:0010648', 'Dermal translucency', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674938, 'HP:0010648', 'Dermal translucency', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674939, 'HP:0010648', 'Dermal translucency', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674940, 'HP:0010648', 'Dermal translucency', 'MP:0003717', 'pallor', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674941, 'HP:0010648', 'Dermal translucency', 'MP:0009385', 'abnormal dermal pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674942, 'HP:0010648', 'Dermal translucency', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674943, 'HP:0010648', 'Dermal translucency', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674944, 'HP:0010648', 'Dermal translucency', 'MP:0003653', 'decreased skin turgor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674945, 'HP:0010648', 'Dermal translucency', 'MP:0001201', 'translucent skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674946, 'HP:0010648', 'Dermal translucency', 'MP:0005508', 'abnormal skeleton morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674947, 'HP:0010648', 'Dermal translucency', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674948, 'HP:0010648', 'Dermal translucency', 'MP:0014273', 'abnormal skin vasculature morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674949, 'HP:0010648', 'Dermal translucency', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(674950, 'HP:0010648', 'Dermal translucency', 'MP:0000402', 'abnormal zigzag hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(674951, 'HP:0010648', 'Dermal translucency', 'MP:0011515', 'purpura', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674952, 'HP:0010648', 'Dermal translucency', 'MP:0001198', 'tight skin', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(674953, 'HP:0200057', 'Marcus Gunn pupil', 'MP:0006186', 'retina fibrosis', 0.4126984126984127, 9.356059413574362, 1.965001493407621, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(674954, 'HP:0200057', 'Marcus Gunn pupil', 'MP:0001326', 'retina degeneration', 0.40625, 9.356059413574362, 1.9495894790351596, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(674955, 'HP:0200057', 'Marcus Gunn pupil', 'MP:0006188', 'calcified retina', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(674956, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674957, 'HP:0011293', 'EEG with central sharp waves', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674958, 'HP:0011293', 'EEG with central sharp waves', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674959, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674960, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674961, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674962, 'HP:0011293', 'EEG with central sharp waves', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674963, 'HP:0011293', 'EEG with central sharp waves', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674964, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674965, 'HP:0011293', 'EEG with central sharp waves', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674966, 'HP:0011293', 'EEG with central sharp waves', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674967, 'HP:0011293', 'EEG with central sharp waves', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674968, 'HP:0011293', 'EEG with central sharp waves', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674969, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674970, 'HP:0011293', 'EEG with central sharp waves', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674971, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674972, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674973, 'HP:0011293', 'EEG with central sharp waves', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674974, 'HP:0011293', 'EEG with central sharp waves', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674975, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674976, 'HP:0011293', 'EEG with central sharp waves', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674977, 'HP:0011293', 'EEG with central sharp waves', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674978, 'HP:0011293', 'EEG with central sharp waves', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674979, 'HP:0011293', 'EEG with central sharp waves', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674980, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674981, 'HP:0011293', 'EEG with central sharp waves', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674982, 'HP:0011293', 'EEG with central sharp waves', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674983, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674984, 'HP:0011293', 'EEG with central sharp waves', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674985, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674986, 'HP:0011293', 'EEG with central sharp waves', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674987, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674988, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674989, 'HP:0011293', 'EEG with central sharp waves', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674990, 'HP:0011293', 'EEG with central sharp waves', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674991, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674992, 'HP:0011293', 'EEG with central sharp waves', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674993, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674994, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674995, 'HP:0011293', 'EEG with central sharp waves', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674996, 'HP:0011293', 'EEG with central sharp waves', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674997, 'HP:0011293', 'EEG with central sharp waves', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674998, 'HP:0011293', 'EEG with central sharp waves', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(674999, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675000, 'HP:0011293', 'EEG with central sharp waves', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675001, 'HP:0011293', 'EEG with central sharp waves', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675002, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675003, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675004, 'HP:0011293', 'EEG with central sharp waves', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675005, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675006, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675007, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675008, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675009, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675010, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675011, 'HP:0011293', 'EEG with central sharp waves', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675012, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675013, 'HP:0011293', 'EEG with central sharp waves', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675014, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675015, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675016, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675017, 'HP:0011293', 'EEG with central sharp waves', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675018, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675019, 'HP:0011293', 'EEG with central sharp waves', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675020, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675021, 'HP:0011293', 'EEG with central sharp waves', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675022, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675023, 'HP:0011293', 'EEG with central sharp waves', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675024, 'HP:0011293', 'EEG with central sharp waves', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(675025, 'HP:0005339', 'Abnormality of complement system', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675026, 'HP:0005339', 'Abnormality of complement system', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675027, 'HP:0005339', 'Abnormality of complement system', 'MP:0004751', 'increased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675028, 'HP:0005339', 'Abnormality of complement system', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675029, 'HP:0005339', 'Abnormality of complement system', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675030, 'HP:0005339', 'Abnormality of complement system', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675031, 'HP:0005339', 'Abnormality of complement system', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675032, 'HP:0005339', 'Abnormality of complement system', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675033, 'HP:0005339', 'Abnormality of complement system', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675034, 'HP:0005339', 'Abnormality of complement system', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675035, 'HP:0005339', 'Abnormality of complement system', 'MP:0001849', 'ear inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675036, 'HP:0005339', 'Abnormality of complement system', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675037, 'HP:0005339', 'Abnormality of complement system', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675038, 'HP:0005339', 'Abnormality of complement system', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675039, 'HP:0005339', 'Abnormality of complement system', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675040, 'HP:0005339', 'Abnormality of complement system', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675041, 'HP:0005339', 'Abnormality of complement system', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675042, 'HP:0005339', 'Abnormality of complement system', 'MP:0010753', 'improved mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675043, 'HP:0005339', 'Abnormality of complement system', 'MP:0031226', 'increased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675044, 'HP:0005339', 'Abnormality of complement system', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675045, 'HP:0005339', 'Abnormality of complement system', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675046, 'HP:0005339', 'Abnormality of complement system', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675047, 'HP:0005339', 'Abnormality of complement system', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675048, 'HP:0005339', 'Abnormality of complement system', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675049, 'HP:0005339', 'Abnormality of complement system', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675050, 'HP:0005339', 'Abnormality of complement system', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675051, 'HP:0005339', 'Abnormality of complement system', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675052, 'HP:0005339', 'Abnormality of complement system', 'MP:0004879', 'decreased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675053, 'HP:0005339', 'Abnormality of complement system', 'MP:0020218', 'abnormal tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675054, 'HP:0005339', 'Abnormality of complement system', 'MP:0030118', 'rhinosinusitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675055, 'HP:0005339', 'Abnormality of complement system', 'MP:0021015', 'increased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675056, 'HP:0005339', 'Abnormality of complement system', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675057, 'HP:0005339', 'Abnormality of complement system', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675058, 'HP:0005339', 'Abnormality of complement system', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675059, 'HP:0005339', 'Abnormality of complement system', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675060, 'HP:0005339', 'Abnormality of complement system', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675061, 'HP:0005339', 'Abnormality of complement system', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675062, 'HP:0005339', 'Abnormality of complement system', 'MP:0001876', 'decreased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675063, 'HP:0005339', 'Abnormality of complement system', 'MP:0008814', 'decreased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675064, 'HP:0005339', 'Abnormality of complement system', 'MP:0001866', 'nasal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675065, 'HP:0005339', 'Abnormality of complement system', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675066, 'HP:0005339', 'Abnormality of complement system', 'MP:0021009', 'abnormal synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675067, 'HP:0005339', 'Abnormality of complement system', 'MP:0011951', 'increased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675068, 'HP:0005339', 'Abnormality of complement system', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675069, 'HP:0005339', 'Abnormality of complement system', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675070, 'HP:0005339', 'Abnormality of complement system', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675071, 'HP:0005339', 'Abnormality of complement system', 'MP:0014120', 'focal seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675072, 'HP:0005339', 'Abnormality of complement system', 'MP:0031110', 'meningitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675073, 'HP:0005339', 'Abnormality of complement system', 'MP:0005000', 'abnormal immune tolerance', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675074, 'HP:0005339', 'Abnormality of complement system', 'MP:0001862', 'interstitial pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675075, 'HP:0005339', 'Abnormality of complement system', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675076, 'HP:0005339', 'Abnormality of complement system', 'MP:0012554', 'increased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675077, 'HP:0005339', 'Abnormality of complement system', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675078, 'HP:0005339', 'Abnormality of complement system', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675079, 'HP:0005339', 'Abnormality of complement system', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675080, 'HP:0005339', 'Abnormality of complement system', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675081, 'HP:0005339', 'Abnormality of complement system', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675082, 'HP:0005339', 'Abnormality of complement system', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675083, 'HP:0005339', 'Abnormality of complement system', 'MP:0020142', 'increased anti-sperm antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675084, 'HP:0005339', 'Abnormality of complement system', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675085, 'HP:0005339', 'Abnormality of complement system', 'MP:0012011', 'febrile seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675086, 'HP:0005339', 'Abnormality of complement system', 'MP:0010751', 'decreased susceptibility to parasitic infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675087, 'HP:0005339', 'Abnormality of complement system', 'MP:0011164', 'panniculitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675088, 'HP:0005339', 'Abnormality of complement system', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675089, 'HP:0005339', 'Abnormality of complement system', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675090, 'HP:0005339', 'Abnormality of complement system', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675091, 'HP:0005339', 'Abnormality of complement system', 'MP:0001790', 'abnormal immune system physiology', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675092, 'HP:0005339', 'Abnormality of complement system', 'MP:0002934', 'acute joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675093, 'HP:0005339', 'Abnormality of complement system', 'MP:0003254', 'bile duct inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675094, 'HP:0005339', 'Abnormality of complement system', 'MP:0002935', 'chronic joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675095, 'HP:0005339', 'Abnormality of complement system', 'MP:0005403', 'abnormal nerve conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675096, 'HP:0005339', 'Abnormality of complement system', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675097, 'HP:0005339', 'Abnormality of complement system', 'MP:0010922', 'alveolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675098, 'HP:0005339', 'Abnormality of complement system', 'MP:0003251', 'gallbladder inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675099, 'HP:0005339', 'Abnormality of complement system', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675100, 'HP:0005339', 'Abnormality of complement system', 'MP:0001841', 'decreased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675101, 'HP:0005339', 'Abnormality of complement system', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675102, 'HP:0005339', 'Abnormality of complement system', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675103, 'HP:0005339', 'Abnormality of complement system', 'MP:0003454', 'erythroderma', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675104, 'HP:0005339', 'Abnormality of complement system', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675105, 'HP:0005339', 'Abnormality of complement system', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675106, 'HP:0005339', 'Abnormality of complement system', 'MP:0009791', 'increased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675107, 'HP:0005339', 'Abnormality of complement system', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675108, 'HP:0005339', 'Abnormality of complement system', 'MP:0011927', 'abnormal cardiac valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675109, 'HP:0005339', 'Abnormality of complement system', 'MP:0008660', 'increased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675110, 'HP:0005339', 'Abnormality of complement system', 'MP:0013479', 'scleritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675111, 'HP:0005339', 'Abnormality of complement system', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675112, 'HP:0005339', 'Abnormality of complement system', 'MP:0002409', 'decreased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675113, 'HP:0005339', 'Abnormality of complement system', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675114, 'HP:0005339', 'Abnormality of complement system', 'MP:0031053', 'pleuritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675115, 'HP:0005339', 'Abnormality of complement system', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675116, 'HP:0005339', 'Abnormality of complement system', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675117, 'HP:0005339', 'Abnormality of complement system', 'MP:0001857', 'pericarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675118, 'HP:0005339', 'Abnormality of complement system', 'MP:0008663', 'increased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675119, 'HP:0005339', 'Abnormality of complement system', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675120, 'HP:0005339', 'Abnormality of complement system', 'MP:0009046', 'muscle twitch', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675121, 'HP:0005339', 'Abnormality of complement system', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675122, 'HP:0005339', 'Abnormality of complement system', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675123, 'HP:0005339', 'Abnormality of complement system', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675124, 'HP:0005339', 'Abnormality of complement system', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675125, 'HP:0005339', 'Abnormality of complement system', 'MP:0013625', 'increased femur yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675126, 'HP:0005339', 'Abnormality of complement system', 'MP:0001846', 'increased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675127, 'HP:0005339', 'Abnormality of complement system', 'MP:0003476', 'decreased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675128, 'HP:0005339', 'Abnormality of complement system', 'MP:0001858', 'intestinal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675129, 'HP:0005339', 'Abnormality of complement system', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675130, 'HP:0005339', 'Abnormality of complement system', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675131, 'HP:0005339', 'Abnormality of complement system', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675132, 'HP:0005339', 'Abnormality of complement system', 'MP:0013460', 'periocular dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675133, 'HP:0005339', 'Abnormality of complement system', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675134, 'HP:0005339', 'Abnormality of complement system', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675135, 'HP:0005339', 'Abnormality of complement system', 'MP:0003889', 'enhanced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675136, 'HP:0005339', 'Abnormality of complement system', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675137, 'HP:0005339', 'Abnormality of complement system', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675138, 'HP:0005339', 'Abnormality of complement system', 'MP:0004142', 'abnormal muscle tone', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675139, 'HP:0005339', 'Abnormality of complement system', 'MP:0030987', 'spinal cord inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675140, 'HP:0005339', 'Abnormality of complement system', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675141, 'HP:0005339', 'Abnormality of complement system', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675142, 'HP:0005339', 'Abnormality of complement system', 'MP:0000343', 'abnormal response to cardiac infarction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675143, 'HP:0005339', 'Abnormality of complement system', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675144, 'HP:0005339', 'Abnormality of complement system', 'MP:0002254', 'reproductive system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675145, 'HP:0005339', 'Abnormality of complement system', 'MP:0001819', 'abnormal immune cell physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675146, 'HP:0005339', 'Abnormality of complement system', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675147, 'HP:0005339', 'Abnormality of complement system', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675148, 'HP:0005339', 'Abnormality of complement system', 'MP:0003463', 'abnormal single cell response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675149, 'HP:0005339', 'Abnormality of complement system', 'MP:0031225', 'decreased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675150, 'HP:0005339', 'Abnormality of complement system', 'MP:0011952', 'decreased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675151, 'HP:0005339', 'Abnormality of complement system', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675152, 'HP:0005339', 'Abnormality of complement system', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675153, 'HP:0005339', 'Abnormality of complement system', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675154, 'HP:0005339', 'Abnormality of complement system', 'MP:0008567', 'decreased interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675155, 'HP:0005339', 'Abnormality of complement system', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675156, 'HP:0005339', 'Abnormality of complement system', 'MP:0030129', 'tongue inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675157, 'HP:0005339', 'Abnormality of complement system', 'MP:0005402', 'abnormal action potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675158, 'HP:0005339', 'Abnormality of complement system', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675159, 'HP:0005339', 'Abnormality of complement system', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675160, 'HP:0005339', 'Abnormality of complement system', 'MP:0031055', 'bronchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675161, 'HP:0005339', 'Abnormality of complement system', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675162, 'HP:0005339', 'Abnormality of complement system', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675163, 'HP:0005339', 'Abnormality of complement system', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675164, 'HP:0005339', 'Abnormality of complement system', 'MP:0008706', 'decreased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675165, 'HP:0005339', 'Abnormality of complement system', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675166, 'HP:0005339', 'Abnormality of complement system', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675167, 'HP:0005339', 'Abnormality of complement system', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675168, 'HP:0005339', 'Abnormality of complement system', 'MP:0009732', 'ventricular premature beat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675169, 'HP:0005339', 'Abnormality of complement system', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675170, 'HP:0005339', 'Abnormality of complement system', 'MP:0013971', 'blood in lymph vessels', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675171, 'HP:0005339', 'Abnormality of complement system', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675172, 'HP:0005339', 'Abnormality of complement system', 'MP:0002419', 'abnormal innate immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675173, 'HP:0005339', 'Abnormality of complement system', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675174, 'HP:0005339', 'Abnormality of complement system', 'MP:0003477', 'abnormal nerve fiber response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675175, 'HP:0005339', 'Abnormality of complement system', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675176, 'HP:0005339', 'Abnormality of complement system', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675177, 'HP:0005339', 'Abnormality of complement system', 'MP:0003278', 'esophageal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675178, 'HP:0005339', 'Abnormality of complement system', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675179, 'HP:0005339', 'Abnormality of complement system', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675180, 'HP:0005339', 'Abnormality of complement system', 'MP:0004085', 'abnormal heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675181, 'HP:0005339', 'Abnormality of complement system', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675182, 'HP:0005339', 'Abnormality of complement system', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675183, 'HP:0005339', 'Abnormality of complement system', 'MP:0001194', 'dermatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675184, 'HP:0005339', 'Abnormality of complement system', 'MP:0008676', 'decreased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675185, 'HP:0005339', 'Abnormality of complement system', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675186, 'HP:0005339', 'Abnormality of complement system', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675187, 'HP:0005339', 'Abnormality of complement system', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675188, 'HP:0005339', 'Abnormality of complement system', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675189, 'HP:0005339', 'Abnormality of complement system', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675190, 'HP:0005339', 'Abnormality of complement system', 'MP:0004752', 'decreased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675191, 'HP:0005339', 'Abnormality of complement system', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675192, 'HP:0005339', 'Abnormality of complement system', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675193, 'HP:0005339', 'Abnormality of complement system', 'MP:0008684', 'increased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675194, 'HP:0005339', 'Abnormality of complement system', 'MP:0031246', 'abnormal CCL3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675195, 'HP:0005339', 'Abnormality of complement system', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675196, 'HP:0005339', 'Abnormality of complement system', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675197, 'HP:0005339', 'Abnormality of complement system', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675198, 'HP:0005339', 'Abnormality of complement system', 'MP:0011925', 'abnormal heart echocardiography feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675199, 'HP:0005339', 'Abnormality of complement system', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675200, 'HP:0005339', 'Abnormality of complement system', 'MP:0003777', 'lip inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675201, 'HP:0005339', 'Abnormality of complement system', 'MP:0008539', 'decreased susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675202, 'HP:0005339', 'Abnormality of complement system', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675203, 'HP:0005339', 'Abnormality of complement system', 'MP:0004994', 'abnormal brain wave pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675204, 'HP:0005339', 'Abnormality of complement system', 'MP:0010515', 'abnormal Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675205, 'HP:0005339', 'Abnormality of complement system', 'MP:0003726', 'decreased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675206, 'HP:0005339', 'Abnormality of complement system', 'MP:0011012', 'bronchiectasis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675207, 'HP:0005339', 'Abnormality of complement system', 'MP:0001752', 'abnormal hypothalamus secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675208, 'HP:0005339', 'Abnormality of complement system', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675209, 'HP:0005339', 'Abnormality of complement system', 'MP:0031054', 'bronchiolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675210, 'HP:0005339', 'Abnormality of complement system', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675211, 'HP:0005339', 'Abnormality of complement system', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675212, 'HP:0005339', 'Abnormality of complement system', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675213, 'HP:0005339', 'Abnormality of complement system', 'MP:0002471', 'abnormal complement pathway', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675214, 'HP:0005339', 'Abnormality of complement system', 'MP:0031471', 'abnormal micropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675215, 'HP:0005339', 'Abnormality of complement system', 'MP:0001851', 'eye inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675216, 'HP:0005339', 'Abnormality of complement system', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675217, 'HP:0005339', 'Abnormality of complement system', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675218, 'HP:0005339', 'Abnormality of complement system', 'MP:0011718', 'decreased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675219, 'HP:0005339', 'Abnormality of complement system', 'MP:0008702', 'increased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675220, 'HP:0005339', 'Abnormality of complement system', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675221, 'HP:0005339', 'Abnormality of complement system', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675222, 'HP:0005339', 'Abnormality of complement system', 'MP:0011763', 'urethritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675223, 'HP:0005339', 'Abnormality of complement system', 'MP:0031247', 'decreased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675224, 'HP:0005339', 'Abnormality of complement system', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675225, 'HP:0005339', 'Abnormality of complement system', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675226, 'HP:0005339', 'Abnormality of complement system', 'MP:0004149', 'increased bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675227, 'HP:0005339', 'Abnormality of complement system', 'MP:0003464', 'abnormal single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675228, 'HP:0005339', 'Abnormality of complement system', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675229, 'HP:0005339', 'Abnormality of complement system', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675230, 'HP:0005339', 'Abnormality of complement system', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675231, 'HP:0005339', 'Abnormality of complement system', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675232, 'HP:0005339', 'Abnormality of complement system', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675233, 'HP:0005339', 'Abnormality of complement system', 'MP:0012609', 'decreased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675234, 'HP:0005339', 'Abnormality of complement system', 'MP:0003929', 'decreased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675235, 'HP:0005339', 'Abnormality of complement system', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675236, 'HP:0005339', 'Abnormality of complement system', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675237, 'HP:0005339', 'Abnormality of complement system', 'MP:0003767', 'palate inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675238, 'HP:0005339', 'Abnormality of complement system', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675239, 'HP:0005339', 'Abnormality of complement system', 'MP:0031066', 'cytokine storm', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675240, 'HP:0005339', 'Abnormality of complement system', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675241, 'HP:0005339', 'Abnormality of complement system', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675242, 'HP:0005339', 'Abnormality of complement system', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675243, 'HP:0005339', 'Abnormality of complement system', 'MP:0020154', 'impaired humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675244, 'HP:0005339', 'Abnormality of complement system', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675245, 'HP:0005339', 'Abnormality of complement system', 'MP:0012555', 'decreased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675246, 'HP:0005339', 'Abnormality of complement system', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675247, 'HP:0005339', 'Abnormality of complement system', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675248, 'HP:0005339', 'Abnormality of complement system', 'MP:0020155', 'enhanced humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675249, 'HP:0005339', 'Abnormality of complement system', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675250, 'HP:0005339', 'Abnormality of complement system', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675251, 'HP:0005339', 'Abnormality of complement system', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675252, 'HP:0005339', 'Abnormality of complement system', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675253, 'HP:0005339', 'Abnormality of complement system', 'MP:0003483', 'decreased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675254, 'HP:0005339', 'Abnormality of complement system', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675255, 'HP:0005339', 'Abnormality of complement system', 'MP:0001844', 'autoimmune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675256, 'HP:0005339', 'Abnormality of complement system', 'MP:0030822', 'sacroiliac joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675257, 'HP:0005339', 'Abnormality of complement system', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675258, 'HP:0005339', 'Abnormality of complement system', 'MP:0003470', 'abnormal summary potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675259, 'HP:0005339', 'Abnormality of complement system', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675260, 'HP:0005339', 'Abnormality of complement system', 'MP:0008669', 'increased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675261, 'HP:0005339', 'Abnormality of complement system', 'MP:0004156', 'abnormal QT variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675262, 'HP:0005339', 'Abnormality of complement system', 'MP:0011013', 'bronchiolectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675263, 'HP:0005339', 'Abnormality of complement system', 'MP:0013208', 'abnormal cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675264, 'HP:0005339', 'Abnormality of complement system', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675265, 'HP:0005339', 'Abnormality of complement system', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675266, 'HP:0005339', 'Abnormality of complement system', 'MP:0008748', 'abnormal central T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675267, 'HP:0005339', 'Abnormality of complement system', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675268, 'HP:0005339', 'Abnormality of complement system', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675269, 'HP:0005339', 'Abnormality of complement system', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675270, 'HP:0005339', 'Abnormality of complement system', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675271, 'HP:0005339', 'Abnormality of complement system', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675272, 'HP:0005339', 'Abnormality of complement system', 'MP:0010071', 'abnormal pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675273, 'HP:0005339', 'Abnormality of complement system', 'MP:0005580', 'periinsulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675274, 'HP:0005339', 'Abnormality of complement system', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675275, 'HP:0005339', 'Abnormality of complement system', 'MP:0003340', 'acute pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675276, 'HP:0005339', 'Abnormality of complement system', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675277, 'HP:0005339', 'Abnormality of complement system', 'MP:0008705', 'increased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675278, 'HP:0005339', 'Abnormality of complement system', 'MP:0003901', 'abnormal PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675279, 'HP:0005339', 'Abnormality of complement system', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675280, 'HP:0005339', 'Abnormality of complement system', 'MP:0031118', 'cardiovalvulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675281, 'HP:0005339', 'Abnormality of complement system', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675282, 'HP:0005339', 'Abnormality of complement system', 'MP:0011717', 'increased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675283, 'HP:0005339', 'Abnormality of complement system', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675284, 'HP:0005339', 'Abnormality of complement system', 'MP:0002500', 'granulomatous inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675285, 'HP:0005339', 'Abnormality of complement system', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675286, 'HP:0005339', 'Abnormality of complement system', 'MP:0001852', 'conjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675287, 'HP:0005339', 'Abnormality of complement system', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675288, 'HP:0005339', 'Abnormality of complement system', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675289, 'HP:0005339', 'Abnormality of complement system', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675290, 'HP:0005339', 'Abnormality of complement system', 'MP:0010560', 'intraventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675291, 'HP:0005339', 'Abnormality of complement system', 'MP:0011929', 'abnormal aortic valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675292, 'HP:0005339', 'Abnormality of complement system', 'MP:0008651', 'increased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675293, 'HP:0005339', 'Abnormality of complement system', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675294, 'HP:0005339', 'Abnormality of complement system', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675295, 'HP:0005339', 'Abnormality of complement system', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675296, 'HP:0005339', 'Abnormality of complement system', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675297, 'HP:0005339', 'Abnormality of complement system', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675298, 'HP:0005339', 'Abnormality of complement system', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675299, 'HP:0005339', 'Abnormality of complement system', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675300, 'HP:0005339', 'Abnormality of complement system', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675301, 'HP:0005339', 'Abnormality of complement system', 'MP:0013498', 'trachea inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675302, 'HP:0005339', 'Abnormality of complement system', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675303, 'HP:0005339', 'Abnormality of complement system', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675304, 'HP:0005339', 'Abnormality of complement system', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675305, 'HP:0005339', 'Abnormality of complement system', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675306, 'HP:0005339', 'Abnormality of complement system', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675307, 'HP:0005339', 'Abnormality of complement system', 'MP:0009792', 'seborrheic dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675308, 'HP:0005339', 'Abnormality of complement system', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675309, 'HP:0005339', 'Abnormality of complement system', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675310, 'HP:0005339', 'Abnormality of complement system', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675311, 'HP:0005339', 'Abnormality of complement system', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675312, 'HP:0005339', 'Abnormality of complement system', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675313, 'HP:0005339', 'Abnormality of complement system', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675314, 'HP:0005339', 'Abnormality of complement system', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675315, 'HP:0005339', 'Abnormality of complement system', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675316, 'HP:0005339', 'Abnormality of complement system', 'MP:0031241', 'decreased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675317, 'HP:0005339', 'Abnormality of complement system', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675318, 'HP:0005339', 'Abnormality of complement system', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675319, 'HP:0005339', 'Abnormality of complement system', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675320, 'HP:0005339', 'Abnormality of complement system', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675321, 'HP:0005339', 'Abnormality of complement system', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675322, 'HP:0005339', 'Abnormality of complement system', 'MP:0003725', 'increased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675323, 'HP:0005339', 'Abnormality of complement system', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675324, 'HP:0005339', 'Abnormality of complement system', 'MP:0001856', 'myocarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675325, 'HP:0005339', 'Abnormality of complement system', 'MP:0031222', 'decreased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675326, 'HP:0005339', 'Abnormality of complement system', 'MP:0008751', 'abnormal interleukin level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675327, 'HP:0005339', 'Abnormality of complement system', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675328, 'HP:0005339', 'Abnormality of complement system', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675329, 'HP:0005339', 'Abnormality of complement system', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675330, 'HP:0005339', 'Abnormality of complement system', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675331, 'HP:0005339', 'Abnormality of complement system', 'MP:0010514', 'fragmented QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675332, 'HP:0005339', 'Abnormality of complement system', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675333, 'HP:0005339', 'Abnormality of complement system', 'MP:0030130', 'gum inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675334, 'HP:0005339', 'Abnormality of complement system', 'MP:0008690', 'increased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675335, 'HP:0005339', 'Abnormality of complement system', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675336, 'HP:0005339', 'Abnormality of complement system', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675337, 'HP:0005339', 'Abnormality of complement system', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675338, 'HP:0005339', 'Abnormality of complement system', 'MP:0008685', 'decreased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675339, 'HP:0005339', 'Abnormality of complement system', 'MP:0030991', 'optic nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675340, 'HP:0005339', 'Abnormality of complement system', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675341, 'HP:0005339', 'Abnormality of complement system', 'MP:0008776', 'increased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675342, 'HP:0005339', 'Abnormality of complement system', 'MP:0002634', 'abnormal sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675343, 'HP:0005339', 'Abnormality of complement system', 'MP:0010505', 'abnormal T wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675344, 'HP:0005339', 'Abnormality of complement system', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675345, 'HP:0005339', 'Abnormality of complement system', 'MP:0002418', 'increased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675346, 'HP:0005339', 'Abnormality of complement system', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675347, 'HP:0005339', 'Abnormality of complement system', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675348, 'HP:0005339', 'Abnormality of complement system', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675349, 'HP:0005339', 'Abnormality of complement system', 'MP:0009698', 'heart hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675350, 'HP:0005339', 'Abnormality of complement system', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675351, 'HP:0005339', 'Abnormality of complement system', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675352, 'HP:0005339', 'Abnormality of complement system', 'MP:0003471', 'abnormal summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675353, 'HP:0005339', 'Abnormality of complement system', 'MP:0011994', 'increased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675354, 'HP:0005339', 'Abnormality of complement system', 'MP:0008699', 'increased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675355, 'HP:0005339', 'Abnormality of complement system', 'MP:0004796', 'increased anti-histone antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675356, 'HP:0005339', 'Abnormality of complement system', 'MP:0005515', 'uveitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675357, 'HP:0005339', 'Abnormality of complement system', 'MP:0004143', 'muscle hypertonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675358, 'HP:0005339', 'Abnormality of complement system', 'MP:0031095', 'pharyngitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675359, 'HP:0005339', 'Abnormality of complement system', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675360, 'HP:0005339', 'Abnormality of complement system', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675361, 'HP:0005339', 'Abnormality of complement system', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675362, 'HP:0005339', 'Abnormality of complement system', 'MP:0003465', 'increased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675363, 'HP:0005339', 'Abnormality of complement system', 'MP:0002498', 'abnormal acute inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675364, 'HP:0005339', 'Abnormality of complement system', 'MP:0008722', 'abnormal chemokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675365, 'HP:0005339', 'Abnormality of complement system', 'MP:0003633', 'abnormal nervous system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675366, 'HP:0005339', 'Abnormality of complement system', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675367, 'HP:0005339', 'Abnormality of complement system', 'MP:0005333', 'decreased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675368, 'HP:0005339', 'Abnormality of complement system', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675369, 'HP:0005339', 'Abnormality of complement system', 'MP:0003481', 'decreased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675370, 'HP:0005339', 'Abnormality of complement system', 'MP:0020001', 'decreased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675371, 'HP:0005339', 'Abnormality of complement system', 'MP:0008708', 'increased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675372, 'HP:0005339', 'Abnormality of complement system', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675373, 'HP:0005339', 'Abnormality of complement system', 'MP:0008688', 'decreased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675374, 'HP:0005339', 'Abnormality of complement system', 'MP:0008691', 'decreased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675375, 'HP:0005339', 'Abnormality of complement system', 'MP:0002635', 'reduced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675376, 'HP:0005339', 'Abnormality of complement system', 'MP:0001793', 'abnormal susceptibility to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675377, 'HP:0005339', 'Abnormality of complement system', 'MP:0001337', 'dry eyes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675378, 'HP:0005339', 'Abnormality of complement system', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675379, 'HP:0005339', 'Abnormality of complement system', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675380, 'HP:0005339', 'Abnormality of complement system', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675381, 'HP:0005339', 'Abnormality of complement system', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675382, 'HP:0005339', 'Abnormality of complement system', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675383, 'HP:0005339', 'Abnormality of complement system', 'MP:0003298', 'choking', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675384, 'HP:0005339', 'Abnormality of complement system', 'MP:0002420', 'abnormal adaptive immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675385, 'HP:0005339', 'Abnormality of complement system', 'MP:0005088', 'increased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675386, 'HP:0005339', 'Abnormality of complement system', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675387, 'HP:0005339', 'Abnormality of complement system', 'MP:0012565', 'perivasculitis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675388, 'HP:0005339', 'Abnormality of complement system', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675389, 'HP:0005339', 'Abnormality of complement system', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675390, 'HP:0005339', 'Abnormality of complement system', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675391, 'HP:0005339', 'Abnormality of complement system', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675392, 'HP:0005339', 'Abnormality of complement system', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675393, 'HP:0005339', 'Abnormality of complement system', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675394, 'HP:0005339', 'Abnormality of complement system', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675395, 'HP:0005339', 'Abnormality of complement system', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675396, 'HP:0005339', 'Abnormality of complement system', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675397, 'HP:0005339', 'Abnormality of complement system', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675398, 'HP:0005339', 'Abnormality of complement system', 'MP:0008682', 'decreased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675399, 'HP:0005339', 'Abnormality of complement system', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675400, 'HP:0005339', 'Abnormality of complement system', 'MP:0001873', 'stomach inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675401, 'HP:0005339', 'Abnormality of complement system', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675402, 'HP:0005339', 'Abnormality of complement system', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675403, 'HP:0005339', 'Abnormality of complement system', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675404, 'HP:0005339', 'Abnormality of complement system', 'MP:0002128', 'abnormal blood circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675405, 'HP:0005339', 'Abnormality of complement system', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675406, 'HP:0005339', 'Abnormality of complement system', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675407, 'HP:0005339', 'Abnormality of complement system', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675408, 'HP:0005339', 'Abnormality of complement system', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675409, 'HP:0005339', 'Abnormality of complement system', 'MP:0001850', 'increased susceptibility to otitis media', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675410, 'HP:0005339', 'Abnormality of complement system', 'MP:0008679', 'decreased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675411, 'HP:0005339', 'Abnormality of complement system', 'MP:0010513', 'abnormal ventricular activation time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675412, 'HP:0005339', 'Abnormality of complement system', 'MP:0013478', 'corneal limbitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675413, 'HP:0005339', 'Abnormality of complement system', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675414, 'HP:0005339', 'Abnormality of complement system', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675415, 'HP:0005339', 'Abnormality of complement system', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675416, 'HP:0005339', 'Abnormality of complement system', 'MP:0020002', 'increased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675417, 'HP:0005339', 'Abnormality of complement system', 'MP:0031302', 'syncope', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675418, 'HP:0005339', 'Abnormality of complement system', 'MP:0004211', 'abnormal sour taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675419, 'HP:0005339', 'Abnormality of complement system', 'MP:0001853', 'heart inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675420, 'HP:0005339', 'Abnormality of complement system', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675421, 'HP:0005339', 'Abnormality of complement system', 'MP:0001872', 'sinus inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675422, 'HP:0005339', 'Abnormality of complement system', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675423, 'HP:0005339', 'Abnormality of complement system', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675424, 'HP:0005339', 'Abnormality of complement system', 'MP:0003009', 'abnormal cytokine secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675425, 'HP:0005339', 'Abnormality of complement system', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675426, 'HP:0005339', 'Abnormality of complement system', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675427, 'HP:0005339', 'Abnormality of complement system', 'MP:0006138', 'congestive heart failure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675428, 'HP:0005339', 'Abnormality of complement system', 'MP:0008696', 'increased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675429, 'HP:0005339', 'Abnormality of complement system', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675430, 'HP:0005339', 'Abnormality of complement system', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675431, 'HP:0005339', 'Abnormality of complement system', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675432, 'HP:0005339', 'Abnormality of complement system', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675433, 'HP:0005339', 'Abnormality of complement system', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675434, 'HP:0005339', 'Abnormality of complement system', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675435, 'HP:0005339', 'Abnormality of complement system', 'MP:0009790', 'decreased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675436, 'HP:0005339', 'Abnormality of complement system', 'MP:0001984', 'abnormal olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675437, 'HP:0005339', 'Abnormality of complement system', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675438, 'HP:0005339', 'Abnormality of complement system', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675439, 'HP:0005339', 'Abnormality of complement system', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675440, 'HP:0005339', 'Abnormality of complement system', 'MP:0009058', 'decreased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675441, 'HP:0005339', 'Abnormality of complement system', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675442, 'HP:0005339', 'Abnormality of complement system', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675443, 'HP:0005339', 'Abnormality of complement system', 'MP:0011920', 'abnormal S wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675444, 'HP:0005339', 'Abnormality of complement system', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675445, 'HP:0005339', 'Abnormality of complement system', 'MP:0002405', 'respiratory system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675446, 'HP:0005339', 'Abnormality of complement system', 'MP:0003341', 'chronic pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675447, 'HP:0005339', 'Abnormality of complement system', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675448, 'HP:0005339', 'Abnormality of complement system', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675449, 'HP:0005339', 'Abnormality of complement system', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675450, 'HP:0005339', 'Abnormality of complement system', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675451, 'HP:0005339', 'Abnormality of complement system', 'MP:0001634', 'internal hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675452, 'HP:0005339', 'Abnormality of complement system', 'MP:0012553', 'decreased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675453, 'HP:0005339', 'Abnormality of complement system', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675454, 'HP:0005339', 'Abnormality of complement system', 'MP:0008664', 'decreased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675455, 'HP:0005339', 'Abnormality of complement system', 'MP:0008747', 'abnormal T cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675456, 'HP:0005339', 'Abnormality of complement system', 'MP:0006194', 'keratoconjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675457, 'HP:0005339', 'Abnormality of complement system', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675458, 'HP:0005339', 'Abnormality of complement system', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675459, 'HP:0005339', 'Abnormality of complement system', 'MP:0008775', 'abnormal heart ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675460, 'HP:0005339', 'Abnormality of complement system', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675461, 'HP:0005339', 'Abnormality of complement system', 'MP:0031129', 'left-to-right shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675462, 'HP:0005339', 'Abnormality of complement system', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675463, 'HP:0005339', 'Abnormality of complement system', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675464, 'HP:0005339', 'Abnormality of complement system', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675465, 'HP:0005339', 'Abnormality of complement system', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675466, 'HP:0005339', 'Abnormality of complement system', 'MP:0010538', 'increased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675467, 'HP:0005339', 'Abnormality of complement system', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675468, 'HP:0005339', 'Abnormality of complement system', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675469, 'HP:0005339', 'Abnormality of complement system', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675470, 'HP:0005339', 'Abnormality of complement system', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675471, 'HP:0005339', 'Abnormality of complement system', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675472, 'HP:0005339', 'Abnormality of complement system', 'MP:0003746', 'stomatitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675473, 'HP:0005339', 'Abnormality of complement system', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675474, 'HP:0005339', 'Abnormality of complement system', 'MP:0002473', 'impaired complement classical pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675475, 'HP:0005339', 'Abnormality of complement system', 'MP:0031051', 'lymph node hemorrhage', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675476, 'HP:0005339', 'Abnormality of complement system', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675477, 'HP:0005339', 'Abnormality of complement system', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675478, 'HP:0005339', 'Abnormality of complement system', 'MP:0008566', 'increased interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675479, 'HP:0005339', 'Abnormality of complement system', 'MP:0030132', 'periodontium inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675480, 'HP:0005339', 'Abnormality of complement system', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675481, 'HP:0005339', 'Abnormality of complement system', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675482, 'HP:0005339', 'Abnormality of complement system', 'MP:0003823', 'increased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675483, 'HP:0005339', 'Abnormality of complement system', 'MP:0008008', 'early cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675484, 'HP:0005339', 'Abnormality of complement system', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675485, 'HP:0005339', 'Abnormality of complement system', 'MP:0003304', 'large intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675486, 'HP:0005339', 'Abnormality of complement system', 'MP:0020000', 'abnormal response to antigen', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675487, 'HP:0005339', 'Abnormality of complement system', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675488, 'HP:0005339', 'Abnormality of complement system', 'MP:0012382', 'abnormal blood cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675489, 'HP:0005339', 'Abnormality of complement system', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675490, 'HP:0005339', 'Abnormality of complement system', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675491, 'HP:0005339', 'Abnormality of complement system', 'MP:0008672', 'increased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675492, 'HP:0005339', 'Abnormality of complement system', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675493, 'HP:0005339', 'Abnormality of complement system', 'MP:0013942', 'enthesitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675494, 'HP:0005339', 'Abnormality of complement system', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675495, 'HP:0005339', 'Abnormality of complement system', 'MP:0003474', 'abnormal summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675496, 'HP:0005339', 'Abnormality of complement system', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675497, 'HP:0005339', 'Abnormality of complement system', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675498, 'HP:0005339', 'Abnormality of complement system', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675499, 'HP:0005339', 'Abnormality of complement system', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675500, 'HP:0005339', 'Abnormality of complement system', 'MP:0004031', 'insulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675501, 'HP:0005339', 'Abnormality of complement system', 'MP:0003665', 'endophthalmitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675502, 'HP:0005339', 'Abnormality of complement system', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675503, 'HP:0005339', 'Abnormality of complement system', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675504, 'HP:0005339', 'Abnormality of complement system', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675505, 'HP:0005339', 'Abnormality of complement system', 'MP:0008687', 'increased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675506, 'HP:0005339', 'Abnormality of complement system', 'MP:0011953', 'prolonged PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675507, 'HP:0005339', 'Abnormality of complement system', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675508, 'HP:0005339', 'Abnormality of complement system', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675509, 'HP:0005339', 'Abnormality of complement system', 'MP:0004037', 'increased muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675510, 'HP:0005339', 'Abnormality of complement system', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675511, 'HP:0005339', 'Abnormality of complement system', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675512, 'HP:0005339', 'Abnormality of complement system', 'MP:0006265', 'increased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675513, 'HP:0005339', 'Abnormality of complement system', 'MP:0008670', 'decreased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675514, 'HP:0005339', 'Abnormality of complement system', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675515, 'HP:0005339', 'Abnormality of complement system', 'MP:0002472', 'impaired complement alternative pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675516, 'HP:0005339', 'Abnormality of complement system', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675517, 'HP:0005339', 'Abnormality of complement system', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675518, 'HP:0005339', 'Abnormality of complement system', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675519, 'HP:0005339', 'Abnormality of complement system', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675520, 'HP:0005339', 'Abnormality of complement system', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675521, 'HP:0005339', 'Abnormality of complement system', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675522, 'HP:0005339', 'Abnormality of complement system', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675523, 'HP:0005339', 'Abnormality of complement system', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675524, 'HP:0005339', 'Abnormality of complement system', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675525, 'HP:0005339', 'Abnormality of complement system', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675526, 'HP:0005339', 'Abnormality of complement system', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675527, 'HP:0005339', 'Abnormality of complement system', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675528, 'HP:0005339', 'Abnormality of complement system', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675529, 'HP:0005339', 'Abnormality of complement system', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675530, 'HP:0005339', 'Abnormality of complement system', 'MP:0031088', 'coughing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675531, 'HP:0005339', 'Abnormality of complement system', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675532, 'HP:0005339', 'Abnormality of complement system', 'MP:0003898', 'abnormal QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675533, 'HP:0005339', 'Abnormality of complement system', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675534, 'HP:0005339', 'Abnormality of complement system', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675535, 'HP:0005339', 'Abnormality of complement system', 'MP:0003475', 'increased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675536, 'HP:0005339', 'Abnormality of complement system', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675537, 'HP:0005339', 'Abnormality of complement system', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675538, 'HP:0005339', 'Abnormality of complement system', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675539, 'HP:0005339', 'Abnormality of complement system', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675540, 'HP:0005339', 'Abnormality of complement system', 'MP:0002406', 'increased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675541, 'HP:0005339', 'Abnormality of complement system', 'MP:0001861', 'lung inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675542, 'HP:0005339', 'Abnormality of complement system', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675543, 'HP:0005339', 'Abnormality of complement system', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675544, 'HP:0005339', 'Abnormality of complement system', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675545, 'HP:0005339', 'Abnormality of complement system', 'MP:0012608', 'abnormal complement C5 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675546, 'HP:0005339', 'Abnormality of complement system', 'MP:0008713', 'abnormal cytokine level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675547, 'HP:0005339', 'Abnormality of complement system', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675548, 'HP:0005339', 'Abnormality of complement system', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675549, 'HP:0005339', 'Abnormality of complement system', 'MP:0031128', 'cardiovascular shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675550, 'HP:0005339', 'Abnormality of complement system', 'MP:0008652', 'decreased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675551, 'HP:0005339', 'Abnormality of complement system', 'MP:0005190', 'osteomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675552, 'HP:0005339', 'Abnormality of complement system', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675553, 'HP:0005339', 'Abnormality of complement system', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675554, 'HP:0005339', 'Abnormality of complement system', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675555, 'HP:0005339', 'Abnormality of complement system', 'MP:0012610', 'increased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675556, 'HP:0005339', 'Abnormality of complement system', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675557, 'HP:0005339', 'Abnormality of complement system', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675558, 'HP:0005339', 'Abnormality of complement system', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675559, 'HP:0005339', 'Abnormality of complement system', 'MP:0011918', 'abnormal PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675560, 'HP:0005339', 'Abnormality of complement system', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675561, 'HP:0005339', 'Abnormality of complement system', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675562, 'HP:0005339', 'Abnormality of complement system', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675563, 'HP:0005339', 'Abnormality of complement system', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675564, 'HP:0005339', 'Abnormality of complement system', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675565, 'HP:0005339', 'Abnormality of complement system', 'MP:0008673', 'decreased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675566, 'HP:0005339', 'Abnormality of complement system', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675567, 'HP:0005339', 'Abnormality of complement system', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675568, 'HP:0005339', 'Abnormality of complement system', 'MP:0001864', 'vascular inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675569, 'HP:0005339', 'Abnormality of complement system', 'MP:0008003', 'achlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675570, 'HP:0005339', 'Abnormality of complement system', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675571, 'HP:0005339', 'Abnormality of complement system', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675572, 'HP:0005339', 'Abnormality of complement system', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675573, 'HP:0005339', 'Abnormality of complement system', 'MP:0009062', 'impaired lectin complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675574, 'HP:0005339', 'Abnormality of complement system', 'MP:0001867', 'rhinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675575, 'HP:0005339', 'Abnormality of complement system', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675576, 'HP:0005339', 'Abnormality of complement system', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675577, 'HP:0005339', 'Abnormality of complement system', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675578, 'HP:0005339', 'Abnormality of complement system', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675579, 'HP:0005339', 'Abnormality of complement system', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675580, 'HP:0005339', 'Abnormality of complement system', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675581, 'HP:0005339', 'Abnormality of complement system', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675582, 'HP:0005339', 'Abnormality of complement system', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675583, 'HP:0005339', 'Abnormality of complement system', 'MP:0001629', 'abnormal heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675584, 'HP:0005339', 'Abnormality of complement system', 'MP:0003560', 'osteoarthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675585, 'HP:0005339', 'Abnormality of complement system', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675586, 'HP:0005339', 'Abnormality of complement system', 'MP:0002578', 'impaired ability to fire action potentials', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675587, 'HP:0005339', 'Abnormality of complement system', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675588, 'HP:0005339', 'Abnormality of complement system', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675589, 'HP:0005339', 'Abnormality of complement system', 'MP:0031223', 'increased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675590, 'HP:0005339', 'Abnormality of complement system', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675591, 'HP:0005339', 'Abnormality of complement system', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675592, 'HP:0005339', 'Abnormality of complement system', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675593, 'HP:0005339', 'Abnormality of complement system', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675594, 'HP:0005339', 'Abnormality of complement system', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675595, 'HP:0005339', 'Abnormality of complement system', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675596, 'HP:0005339', 'Abnormality of complement system', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675597, 'HP:0005339', 'Abnormality of complement system', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675598, 'HP:0005339', 'Abnormality of complement system', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675599, 'HP:0005339', 'Abnormality of complement system', 'MP:0008697', 'decreased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675600, 'HP:0005339', 'Abnormality of complement system', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675601, 'HP:0005339', 'Abnormality of complement system', 'MP:0008681', 'increased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675602, 'HP:0005339', 'Abnormality of complement system', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675603, 'HP:0005339', 'Abnormality of complement system', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675604, 'HP:0005339', 'Abnormality of complement system', 'MP:0000947', 'convulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675605, 'HP:0005339', 'Abnormality of complement system', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675606, 'HP:0005339', 'Abnormality of complement system', 'MP:0008700', 'decreased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675607, 'HP:0005339', 'Abnormality of complement system', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675608, 'HP:0005339', 'Abnormality of complement system', 'MP:0005251', 'blepharitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675609, 'HP:0005339', 'Abnormality of complement system', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675610, 'HP:0005339', 'Abnormality of complement system', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675611, 'HP:0005339', 'Abnormality of complement system', 'MP:0003473', 'decreased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675612, 'HP:0005339', 'Abnormality of complement system', 'MP:0003306', 'small intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675613, 'HP:0005339', 'Abnormality of complement system', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675614, 'HP:0005339', 'Abnormality of complement system', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675615, 'HP:0005339', 'Abnormality of complement system', 'MP:0003659', 'abnormal lymph circulation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675616, 'HP:0005339', 'Abnormality of complement system', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675617, 'HP:0005339', 'Abnormality of complement system', 'MP:0010750', 'increased susceptibility to parasitic infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675618, 'HP:0005339', 'Abnormality of complement system', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675619, 'HP:0005339', 'Abnormality of complement system', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675620, 'HP:0005339', 'Abnormality of complement system', 'MP:0008563', 'decreased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675621, 'HP:0005339', 'Abnormality of complement system', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675622, 'HP:0005339', 'Abnormality of complement system', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675623, 'HP:0005339', 'Abnormality of complement system', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675624, 'HP:0005339', 'Abnormality of complement system', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675625, 'HP:0005339', 'Abnormality of complement system', 'MP:0003091', 'abnormal cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675626, 'HP:0005339', 'Abnormality of complement system', 'MP:0002328', 'abnormal airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675627, 'HP:0005339', 'Abnormality of complement system', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675628, 'HP:0005339', 'Abnormality of complement system', 'MP:0008711', 'increased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675629, 'HP:0005339', 'Abnormality of complement system', 'MP:0010634', 'increased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675630, 'HP:0005339', 'Abnormality of complement system', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675631, 'HP:0005339', 'Abnormality of complement system', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675632, 'HP:0005339', 'Abnormality of complement system', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675633, 'HP:0005339', 'Abnormality of complement system', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675634, 'HP:0005339', 'Abnormality of complement system', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675635, 'HP:0005339', 'Abnormality of complement system', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675636, 'HP:0005339', 'Abnormality of complement system', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675637, 'HP:0005339', 'Abnormality of complement system', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675638, 'HP:0005339', 'Abnormality of complement system', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675639, 'HP:0005339', 'Abnormality of complement system', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675640, 'HP:0005339', 'Abnormality of complement system', 'MP:0001854', 'atrial endocarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675641, 'HP:0005339', 'Abnormality of complement system', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675642, 'HP:0005339', 'Abnormality of complement system', 'MP:0003762', 'abnormal immune organ physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675643, 'HP:0005339', 'Abnormality of complement system', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675644, 'HP:0005339', 'Abnormality of complement system', 'MP:0005004', 'abnormal lymphocyte anergy', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675645, 'HP:0005339', 'Abnormality of complement system', 'MP:0011764', 'ureteritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675646, 'HP:0005339', 'Abnormality of complement system', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675647, 'HP:0005339', 'Abnormality of complement system', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675648, 'HP:0005339', 'Abnormality of complement system', 'MP:0005043', 'defective assembly of class II molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675649, 'HP:0005339', 'Abnormality of complement system', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675650, 'HP:0005339', 'Abnormality of complement system', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675651, 'HP:0005339', 'Abnormality of complement system', 'MP:0003039', 'increased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675652, 'HP:0005339', 'Abnormality of complement system', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675653, 'HP:0005339', 'Abnormality of complement system', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675654, 'HP:0005339', 'Abnormality of complement system', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675655, 'HP:0005339', 'Abnormality of complement system', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675656, 'HP:0005339', 'Abnormality of complement system', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675657, 'HP:0005339', 'Abnormality of complement system', 'MP:0004510', 'myositis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675658, 'HP:0005339', 'Abnormality of complement system', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675659, 'HP:0005339', 'Abnormality of complement system', 'MP:0008737', 'abnormal spleen physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675660, 'HP:0005339', 'Abnormality of complement system', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675661, 'HP:0005339', 'Abnormality of complement system', 'MP:0003480', 'increased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675662, 'HP:0005339', 'Abnormality of complement system', 'MP:0003482', 'increased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675663, 'HP:0005339', 'Abnormality of complement system', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675664, 'HP:0005339', 'Abnormality of complement system', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675665, 'HP:0005339', 'Abnormality of complement system', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675666, 'HP:0005339', 'Abnormality of complement system', 'MP:0020846', 'abnormal cell motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675667, 'HP:0005339', 'Abnormality of complement system', 'MP:0004046', 'abnormal mitosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675668, 'HP:0005339', 'Abnormality of complement system', 'MP:0012006', 'abnormal hippocampus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675669, 'HP:0005339', 'Abnormality of complement system', 'MP:0003393', 'decreased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675670, 'HP:0005339', 'Abnormality of complement system', 'MP:0005044', 'sepsis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675671, 'HP:0005339', 'Abnormality of complement system', 'MP:0010741', 'abnormal melanocyte proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675672, 'HP:0005339', 'Abnormality of complement system', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675673, 'HP:0005339', 'Abnormality of complement system', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675674, 'HP:0005339', 'Abnormality of complement system', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675675, 'HP:0005339', 'Abnormality of complement system', 'MP:0001934', 'increased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675676, 'HP:0005339', 'Abnormality of complement system', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675677, 'HP:0005339', 'Abnormality of complement system', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675678, 'HP:0005339', 'Abnormality of complement system', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675679, 'HP:0005339', 'Abnormality of complement system', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675680, 'HP:0005339', 'Abnormality of complement system', 'MP:0008712', 'decreased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675681, 'HP:0005339', 'Abnormality of complement system', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675682, 'HP:0005339', 'Abnormality of complement system', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675683, 'HP:0005339', 'Abnormality of complement system', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675684, 'HP:0005339', 'Abnormality of complement system', 'MP:0008564', 'increased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675685, 'HP:0005339', 'Abnormality of complement system', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675686, 'HP:0005339', 'Abnormality of complement system', 'MP:0003741', 'tinnitus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675687, 'HP:0005339', 'Abnormality of complement system', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675688, 'HP:0005339', 'Abnormality of complement system', 'MP:0008750', 'abnormal interferon level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675689, 'HP:0005339', 'Abnormality of complement system', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675690, 'HP:0005339', 'Abnormality of complement system', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675691, 'HP:0005339', 'Abnormality of complement system', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675692, 'HP:0005339', 'Abnormality of complement system', 'MP:0001912', 'increased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675693, 'HP:0005339', 'Abnormality of complement system', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675694, 'HP:0005339', 'Abnormality of complement system', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675695, 'HP:0005339', 'Abnormality of complement system', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675696, 'HP:0005339', 'Abnormality of complement system', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675697, 'HP:0005339', 'Abnormality of complement system', 'MP:0002327', 'abnormal respiratory function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675698, 'HP:0005339', 'Abnormality of complement system', 'MP:0031242', 'increased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675699, 'HP:0005339', 'Abnormality of complement system', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675700, 'HP:0005339', 'Abnormality of complement system', 'MP:0008703', 'decreased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675701, 'HP:0005339', 'Abnormality of complement system', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675702, 'HP:0005339', 'Abnormality of complement system', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675703, 'HP:0005339', 'Abnormality of complement system', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675704, 'HP:0005339', 'Abnormality of complement system', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675705, 'HP:0005339', 'Abnormality of complement system', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675706, 'HP:0005339', 'Abnormality of complement system', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675707, 'HP:0005339', 'Abnormality of complement system', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675708, 'HP:0005339', 'Abnormality of complement system', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675709, 'HP:0005339', 'Abnormality of complement system', 'MP:0013806', 'encephalopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675710, 'HP:0005339', 'Abnormality of complement system', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675711, 'HP:0005339', 'Abnormality of complement system', 'MP:0013459', 'perioral dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675712, 'HP:0005339', 'Abnormality of complement system', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675713, 'HP:0005339', 'Abnormality of complement system', 'MP:0031224', 'abnormal CXCL10 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675714, 'HP:0005339', 'Abnormality of complement system', 'MP:0010571', 'shortened ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675715, 'HP:0005339', 'Abnormality of complement system', 'MP:0005364', 'increased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675716, 'HP:0005339', 'Abnormality of complement system', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675717, 'HP:0005339', 'Abnormality of complement system', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675718, 'HP:0005339', 'Abnormality of complement system', 'MP:0013642', 'decreased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675719, 'HP:0005339', 'Abnormality of complement system', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675720, 'HP:0005339', 'Abnormality of complement system', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675721, 'HP:0005339', 'Abnormality of complement system', 'MP:0001800', 'abnormal humoral immune response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675722, 'HP:0005339', 'Abnormality of complement system', 'MP:0011928', 'abnormal mitral valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675723, 'HP:0005339', 'Abnormality of complement system', 'MP:0003865', 'lymph node inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675724, 'HP:0005339', 'Abnormality of complement system', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675725, 'HP:0005339', 'Abnormality of complement system', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675726, 'HP:0005339', 'Abnormality of complement system', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675727, 'HP:0005339', 'Abnormality of complement system', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675728, 'HP:0005339', 'Abnormality of complement system', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675729, 'HP:0005339', 'Abnormality of complement system', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675730, 'HP:0005339', 'Abnormality of complement system', 'MP:0008942', 'abnormal induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675731, 'HP:0005339', 'Abnormality of complement system', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675732, 'HP:0005339', 'Abnormality of complement system', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675733, 'HP:0005339', 'Abnormality of complement system', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675734, 'HP:0005339', 'Abnormality of complement system', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675735, 'HP:0005339', 'Abnormality of complement system', 'MP:0000327', 'hemosiderinuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675736, 'HP:0005339', 'Abnormality of complement system', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675737, 'HP:0005339', 'Abnormality of complement system', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675738, 'HP:0005339', 'Abnormality of complement system', 'MP:0001835', 'abnormal antigen presentation', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675739, 'HP:0005339', 'Abnormality of complement system', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675740, 'HP:0005339', 'Abnormality of complement system', 'MP:0031240', 'abnormal CSF3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675741, 'HP:0005339', 'Abnormality of complement system', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675742, 'HP:0005339', 'Abnormality of complement system', 'MP:0010028', 'aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675743, 'HP:0005339', 'Abnormality of complement system', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675744, 'HP:0005339', 'Abnormality of complement system', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675745, 'HP:0005339', 'Abnormality of complement system', 'MP:0008568', 'abnormal interleukin secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675746, 'HP:0005339', 'Abnormality of complement system', 'MP:0011919', 'abnormal R wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675747, 'HP:0005339', 'Abnormality of complement system', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675748, 'HP:0005339', 'Abnormality of complement system', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675749, 'HP:0005339', 'Abnormality of complement system', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675750, 'HP:0005339', 'Abnormality of complement system', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675751, 'HP:0005339', 'Abnormality of complement system', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675752, 'HP:0005339', 'Abnormality of complement system', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675753, 'HP:0005339', 'Abnormality of complement system', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675754, 'HP:0005339', 'Abnormality of complement system', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675755, 'HP:0005339', 'Abnormality of complement system', 'MP:0005005', 'abnormal self tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675756, 'HP:0005339', 'Abnormality of complement system', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675757, 'HP:0005339', 'Abnormality of complement system', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675758, 'HP:0005339', 'Abnormality of complement system', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675759, 'HP:0005339', 'Abnormality of complement system', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675760, 'HP:0005339', 'Abnormality of complement system', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675761, 'HP:0005339', 'Abnormality of complement system', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675762, 'HP:0005339', 'Abnormality of complement system', 'MP:0012745', 'abnormal neural crest cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675763, 'HP:0005339', 'Abnormality of complement system', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675764, 'HP:0005339', 'Abnormality of complement system', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675765, 'HP:0005339', 'Abnormality of complement system', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675766, 'HP:0005339', 'Abnormality of complement system', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675767, 'HP:0005339', 'Abnormality of complement system', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675768, 'HP:0005339', 'Abnormality of complement system', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675769, 'HP:0005339', 'Abnormality of complement system', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675770, 'HP:0005339', 'Abnormality of complement system', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675771, 'HP:0005339', 'Abnormality of complement system', 'MP:0010539', 'decreased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675772, 'HP:0005339', 'Abnormality of complement system', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675773, 'HP:0005339', 'Abnormality of complement system', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675774, 'HP:0005339', 'Abnormality of complement system', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675775, 'HP:0005339', 'Abnormality of complement system', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675776, 'HP:0005339', 'Abnormality of complement system', 'MP:0008675', 'increased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675777, 'HP:0005339', 'Abnormality of complement system', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675778, 'HP:0005339', 'Abnormality of complement system', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675779, 'HP:0005339', 'Abnormality of complement system', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675780, 'HP:0005339', 'Abnormality of complement system', 'MP:0003466', 'decreased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675781, 'HP:0005339', 'Abnormality of complement system', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675782, 'HP:0005339', 'Abnormality of complement system', 'MP:0003472', 'increased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675783, 'HP:0005339', 'Abnormality of complement system', 'MP:0011954', 'shortened PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675784, 'HP:0005339', 'Abnormality of complement system', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675785, 'HP:0005339', 'Abnormality of complement system', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675786, 'HP:0005339', 'Abnormality of complement system', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675787, 'HP:0005339', 'Abnormality of complement system', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675788, 'HP:0005339', 'Abnormality of complement system', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675789, 'HP:0005339', 'Abnormality of complement system', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675790, 'HP:0005339', 'Abnormality of complement system', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675791, 'HP:0005339', 'Abnormality of complement system', 'MP:0003469', 'decreased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675792, 'HP:0005339', 'Abnormality of complement system', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675793, 'HP:0005339', 'Abnormality of complement system', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675794, 'HP:0005339', 'Abnormality of complement system', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675795, 'HP:0005339', 'Abnormality of complement system', 'MP:0004145', 'abnormal muscle electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675796, 'HP:0005339', 'Abnormality of complement system', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675797, 'HP:0005339', 'Abnormality of complement system', 'MP:0002064', 'seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675798, 'HP:0005339', 'Abnormality of complement system', 'MP:0004947', 'skin inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675799, 'HP:0005339', 'Abnormality of complement system', 'MP:0001869', 'pancreas inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675800, 'HP:0005339', 'Abnormality of complement system', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675801, 'HP:0005339', 'Abnormality of complement system', 'MP:0001837', 'defective assembly of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675802, 'HP:0005339', 'Abnormality of complement system', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675803, 'HP:0005339', 'Abnormality of complement system', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675804, 'HP:0005339', 'Abnormality of complement system', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675805, 'HP:0005339', 'Abnormality of complement system', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675806, 'HP:0005339', 'Abnormality of complement system', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675807, 'HP:0005339', 'Abnormality of complement system', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675808, 'HP:0005339', 'Abnormality of complement system', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675809, 'HP:0005339', 'Abnormality of complement system', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675810, 'HP:0005339', 'Abnormality of complement system', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675811, 'HP:0005339', 'Abnormality of complement system', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675812, 'HP:0005339', 'Abnormality of complement system', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675813, 'HP:0005339', 'Abnormality of complement system', 'MP:0003468', 'increased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675814, 'HP:0005339', 'Abnormality of complement system', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675815, 'HP:0005339', 'Abnormality of complement system', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675816, 'HP:0005339', 'Abnormality of complement system', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675817, 'HP:0005339', 'Abnormality of complement system', 'MP:0003467', 'abnormal single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675818, 'HP:0005339', 'Abnormality of complement system', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675819, 'HP:0005339', 'Abnormality of complement system', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675820, 'HP:0005339', 'Abnormality of complement system', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675821, 'HP:0005339', 'Abnormality of complement system', 'MP:0030153', 'dental pulp inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675822, 'HP:0005339', 'Abnormality of complement system', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675823, 'HP:0005339', 'Abnormality of complement system', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675824, 'HP:0005339', 'Abnormality of complement system', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675825, 'HP:0005339', 'Abnormality of complement system', 'MP:0031111', 'meningoencephalitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675826, 'HP:0005339', 'Abnormality of complement system', 'MP:0008678', 'increased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675827, 'HP:0005339', 'Abnormality of complement system', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675828, 'HP:0005339', 'Abnormality of complement system', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675829, 'HP:0005339', 'Abnormality of complement system', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675830, 'HP:0005339', 'Abnormality of complement system', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675831, 'HP:0005339', 'Abnormality of complement system', 'MP:0008693', 'increased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675832, 'HP:0005339', 'Abnormality of complement system', 'MP:0001845', 'abnormal inflammatory response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675833, 'HP:0005339', 'Abnormality of complement system', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675834, 'HP:0005339', 'Abnormality of complement system', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675835, 'HP:0005339', 'Abnormality of complement system', 'MP:0009788', 'increased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675836, 'HP:0005339', 'Abnormality of complement system', 'MP:0002933', 'joint inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675837, 'HP:0005339', 'Abnormality of complement system', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675838, 'HP:0005339', 'Abnormality of complement system', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675839, 'HP:0005339', 'Abnormality of complement system', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675840, 'HP:0005339', 'Abnormality of complement system', 'MP:0008562', 'increased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675841, 'HP:0005339', 'Abnormality of complement system', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675842, 'HP:0005339', 'Abnormality of complement system', 'MP:0006114', 'cardiac murmur', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675843, 'HP:0005339', 'Abnormality of complement system', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675844, 'HP:0005339', 'Abnormality of complement system', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675845, 'HP:0005339', 'Abnormality of complement system', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675846, 'HP:0005339', 'Abnormality of complement system', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675847, 'HP:0005339', 'Abnormality of complement system', 'MP:0003547', 'abnormal pulmonary pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675848, 'HP:0005339', 'Abnormality of complement system', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675849, 'HP:0005339', 'Abnormality of complement system', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675850, 'HP:0005339', 'Abnormality of complement system', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675851, 'HP:0005339', 'Abnormality of complement system', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675852, 'HP:0005339', 'Abnormality of complement system', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675853, 'HP:0005339', 'Abnormality of complement system', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675854, 'HP:0005339', 'Abnormality of complement system', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675855, 'HP:0005339', 'Abnormality of complement system', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675856, 'HP:0005339', 'Abnormality of complement system', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675857, 'HP:0005339', 'Abnormality of complement system', 'MP:0000951', 'sporadic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675858, 'HP:0005339', 'Abnormality of complement system', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675859, 'HP:0005339', 'Abnormality of complement system', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675860, 'HP:0005339', 'Abnormality of complement system', 'MP:0009789', 'decreased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675861, 'HP:0005339', 'Abnormality of complement system', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675862, 'HP:0005339', 'Abnormality of complement system', 'MP:0005025', 'abnormal response to infection', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675863, 'HP:0005339', 'Abnormality of complement system', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675864, 'HP:0005339', 'Abnormality of complement system', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675865, 'HP:0005339', 'Abnormality of complement system', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675866, 'HP:0005339', 'Abnormality of complement system', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675867, 'HP:0005339', 'Abnormality of complement system', 'MP:0011926', 'abnormal heart valve physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675868, 'HP:0005339', 'Abnormality of complement system', 'MP:0002499', 'chronic inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675869, 'HP:0005339', 'Abnormality of complement system', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675870, 'HP:0005339', 'Abnormality of complement system', 'MP:0001840', 'increased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675871, 'HP:0005339', 'Abnormality of complement system', 'MP:0001756', 'abnormal urination', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675872, 'HP:0005339', 'Abnormality of complement system', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675873, 'HP:0005339', 'Abnormality of complement system', 'MP:0010211', 'abnormal acute phase protein level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675874, 'HP:0005339', 'Abnormality of complement system', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675875, 'HP:0005339', 'Abnormality of complement system', 'MP:0014046', 'abnormal mitophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675876, 'HP:0005339', 'Abnormality of complement system', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675877, 'HP:0005339', 'Abnormality of complement system', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675878, 'HP:0005339', 'Abnormality of complement system', 'MP:0009384', 'cardiac valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675879, 'HP:0005339', 'Abnormality of complement system', 'MP:0008565', 'decreased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675880, 'HP:0005339', 'Abnormality of complement system', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675881, 'HP:0005339', 'Abnormality of complement system', 'MP:0003880', 'abnormal central pattern generator function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675882, 'HP:0005339', 'Abnormality of complement system', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675883, 'HP:0005339', 'Abnormality of complement system', 'MP:0010553', 'prolonged HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675884, 'HP:0005339', 'Abnormality of complement system', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675885, 'HP:0005339', 'Abnormality of complement system', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675886, 'HP:0005339', 'Abnormality of complement system', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675887, 'HP:0005339', 'Abnormality of complement system', 'MP:0011762', 'renal/urinary system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675888, 'HP:0005339', 'Abnormality of complement system', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675889, 'HP:0005339', 'Abnormality of complement system', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675890, 'HP:0005339', 'Abnormality of complement system', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675891, 'HP:0005339', 'Abnormality of complement system', 'MP:0000948', 'nonconvulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675892, 'HP:0005339', 'Abnormality of complement system', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675893, 'HP:0005339', 'Abnormality of complement system', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675894, 'HP:0005339', 'Abnormality of complement system', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675895, 'HP:0005339', 'Abnormality of complement system', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675896, 'HP:0005339', 'Abnormality of complement system', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675897, 'HP:0005339', 'Abnormality of complement system', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675898, 'HP:0005339', 'Abnormality of complement system', 'MP:0020386', 'adipose tissue inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675899, 'HP:0005339', 'Abnormality of complement system', 'MP:0001596', 'hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675900, 'HP:0005339', 'Abnormality of complement system', 'MP:0004558', 'delayed allantois development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675901, 'HP:0005339', 'Abnormality of complement system', 'MP:0011938', 'prolonged PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675902, 'HP:0005339', 'Abnormality of complement system', 'MP:0001313', 'increased incidence of corneal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675903, 'HP:0005339', 'Abnormality of complement system', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675904, 'HP:0005339', 'Abnormality of complement system', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675905, 'HP:0005339', 'Abnormality of complement system', 'MP:0031248', 'increased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675906, 'HP:0005339', 'Abnormality of complement system', 'MP:0008666', 'increased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675907, 'HP:0005339', 'Abnormality of complement system', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675908, 'HP:0005339', 'Abnormality of complement system', 'MP:0008721', 'abnormal chemokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675909, 'HP:0005339', 'Abnormality of complement system', 'MP:0002896', 'abnormal bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675910, 'HP:0005339', 'Abnormality of complement system', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675911, 'HP:0005339', 'Abnormality of complement system', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675912, 'HP:0005339', 'Abnormality of complement system', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675913, 'HP:0005339', 'Abnormality of complement system', 'MP:0011566', 'abnormal complement protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675914, 'HP:0005339', 'Abnormality of complement system', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675915, 'HP:0005339', 'Abnormality of complement system', 'MP:0031125', 'aspiration pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675916, 'HP:0005339', 'Abnormality of complement system', 'MP:0002993', 'arthritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675917, 'HP:0005339', 'Abnormality of complement system', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675918, 'HP:0005339', 'Abnormality of complement system', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675919, 'HP:0005339', 'Abnormality of complement system', 'MP:0031170', 'abnormal vasculature physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675920, 'HP:0005339', 'Abnormality of complement system', 'MP:0013752', 'stridor', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675921, 'HP:0005339', 'Abnormality of complement system', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675922, 'HP:0005339', 'Abnormality of complement system', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675923, 'HP:0005339', 'Abnormality of complement system', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675924, 'HP:0005339', 'Abnormality of complement system', 'MP:0008555', 'abnormal interferon secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675925, 'HP:0005339', 'Abnormality of complement system', 'MP:0005001', 'abnormal clonal deletion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675926, 'HP:0005339', 'Abnormality of complement system', 'MP:0005671', 'abnormal response to transplant', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675927, 'HP:0005339', 'Abnormality of complement system', 'MP:0000231', 'hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675928, 'HP:0005339', 'Abnormality of complement system', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675929, 'HP:0005339', 'Abnormality of complement system', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675930, 'HP:0005339', 'Abnormality of complement system', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675931, 'HP:0005339', 'Abnormality of complement system', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675932, 'HP:0005339', 'Abnormality of complement system', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675933, 'HP:0005339', 'Abnormality of complement system', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675934, 'HP:0005339', 'Abnormality of complement system', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675935, 'HP:0005339', 'Abnormality of complement system', 'MP:0008661', 'decreased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675936, 'HP:0005339', 'Abnormality of complement system', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675937, 'HP:0005339', 'Abnormality of complement system', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675938, 'HP:0005339', 'Abnormality of complement system', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675939, 'HP:0005339', 'Abnormality of complement system', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675940, 'HP:0005339', 'Abnormality of complement system', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675941, 'HP:0005339', 'Abnormality of complement system', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675942, 'HP:0005339', 'Abnormality of complement system', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675943, 'HP:0005339', 'Abnormality of complement system', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675944, 'HP:0005339', 'Abnormality of complement system', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675945, 'HP:0005339', 'Abnormality of complement system', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675946, 'HP:0005339', 'Abnormality of complement system', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675947, 'HP:0005339', 'Abnormality of complement system', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675948, 'HP:0005339', 'Abnormality of complement system', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675949, 'HP:0005339', 'Abnormality of complement system', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675950, 'HP:0005339', 'Abnormality of complement system', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675951, 'HP:0005339', 'Abnormality of complement system', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675952, 'HP:0005339', 'Abnormality of complement system', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675953, 'HP:0005339', 'Abnormality of complement system', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675954, 'HP:0005339', 'Abnormality of complement system', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675955, 'HP:0005339', 'Abnormality of complement system', 'MP:0010381', 'abnormal dosage compensation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675956, 'HP:0005339', 'Abnormality of complement system', 'MP:0013145', 'eye discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675957, 'HP:0005339', 'Abnormality of complement system', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675958, 'HP:0005339', 'Abnormality of complement system', 'MP:0003303', 'peritoneal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675959, 'HP:0005339', 'Abnormality of complement system', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675960, 'HP:0005339', 'Abnormality of complement system', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675961, 'HP:0005339', 'Abnormality of complement system', 'MP:0010519', 'atrioventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675962, 'HP:0005339', 'Abnormality of complement system', 'MP:0011045', 'decreased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675963, 'HP:0005339', 'Abnormality of complement system', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675964, 'HP:0005339', 'Abnormality of complement system', 'MP:0000423', 'delayed hair regrowth', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675965, 'HP:0005339', 'Abnormality of complement system', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675966, 'HP:0005339', 'Abnormality of complement system', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675967, 'HP:0005339', 'Abnormality of complement system', 'MP:0009057', 'increased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675968, 'HP:0005339', 'Abnormality of complement system', 'MP:0006080', 'brain ischemia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675969, 'HP:0005339', 'Abnormality of complement system', 'MP:0010559', 'heart block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675970, 'HP:0005339', 'Abnormality of complement system', 'MP:0008744', 'abnormal B cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675971, 'HP:0005339', 'Abnormality of complement system', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675972, 'HP:0005339', 'Abnormality of complement system', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675973, 'HP:0005339', 'Abnormality of complement system', 'MP:0008709', 'decreased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675974, 'HP:0005339', 'Abnormality of complement system', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675975, 'HP:0005339', 'Abnormality of complement system', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675976, 'HP:0005339', 'Abnormality of complement system', 'MP:0001533', 'abnormal skeleton physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675977, 'HP:0005339', 'Abnormality of complement system', 'MP:0030990', 'nerve inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675978, 'HP:0005339', 'Abnormality of complement system', 'MP:0005087', 'decreased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(675979, 'HP:0005339', 'Abnormality of complement system', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675980, 'HP:0010814', 'Abnormal position of hair whorl', 'MP:0000384', 'distorted hair follicle pattern', 0.40816326530612246, 9.74502654242278, 1.9943825746456256, 'UPHENO:0086475', 'abnormal pilosebaceous unit morphology'),
(675981, 'HP:0010814', 'Abnormal position of hair whorl', 'MP:0013111', 'greasy abdomen coat', 0.41509433962264153, 9.944182255188846, 2.031692340465161, 'UPHENO:0075677', 'abnormal strand of hair'),
(675982, 'HP:0010814', 'Abnormal position of hair whorl', 'MP:0003849', 'greasy coat', 0.4230769230769231, 9.944182255188846, 2.0511348154232656, 'UPHENO:0075677', 'abnormal strand of hair'),
(675983, 'HP:0010814', 'Abnormal position of hair whorl', 'MP:0010142', 'disorganized hair shaft', 0.43137254901960786, 9.944182255188846, 2.071146360674775, 'UPHENO:0075677', 'abnormal strand of hair'),
(675984, 'HP:0010814', 'Abnormal position of hair whorl', 'MP:0009270', 'abnormal guard hair length', 0.4074074074074074, 9.944182255188846, 2.012792466046421, 'UPHENO:0075677', 'abnormal strand of hair'),
(675985, 'HP:0010814', 'Abnormal position of hair whorl', 'MP:0013112', 'greasy thorax coat', 0.41509433962264153, 9.944182255188846, 2.031692340465161, 'UPHENO:0075677', 'abnormal strand of hair'),
(675986, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675987, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675988, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675989, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675990, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675991, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675992, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003482', 'increased nerve fiber response threshold', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675993, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675994, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675995, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675996, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675997, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675998, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012011', 'febrile seizures', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(675999, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.5333333333333333, 14.104646927382092, 2.742713685616938, 'UPHENO:0002259', 'abnormality of autonomic nervous system physiology'),
(676000, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676001, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.47058823529411764, 14.104646927382092, 2.576330900137507, 'UPHENO:0002259', 'abnormality of autonomic nervous system physiology'),
(676002, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676003, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676004, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676005, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676006, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676007, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676008, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002634', 'abnormal sensorimotor gating', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676009, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676010, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003474', 'abnormal summary potential intensity', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676011, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676012, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002635', 'reduced sensorimotor gating', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676013, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676014, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676015, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003466', 'decreased single cell response threshold', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676016, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676017, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676018, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676019, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676020, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676021, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001752', 'abnormal hypothalamus secretion', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676022, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676023, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676024, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676025, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003469', 'decreased single cell response intensity', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676026, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0009358', 'environmentally induced seizures', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676027, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676028, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676029, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676030, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676031, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676032, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676033, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676034, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003465', 'increased single cell response threshold', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676035, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003470', 'abnormal summary potential', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676036, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676037, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676038, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676039, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676040, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676041, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676042, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000951', 'sporadic seizures', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676043, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676044, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003476', 'decreased summary potential intensity', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676045, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676046, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676047, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676048, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676049, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676050, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676051, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000920', 'abnormal myelination', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676052, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002826', 'tonic seizures', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676053, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004513', 'avnosmia', 0.45161290322580644, 6.644251262574015, 1.7322325486067915, 'UPHENO:0005116', 'abnormal peripheral nervous system'),
(676054, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0021009', 'abnormal synaptic physiology', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676055, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676056, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676057, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676058, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676059, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676060, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676061, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676062, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676063, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676064, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003216', 'absence seizures', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676065, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676066, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676067, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002578', 'impaired ability to fire action potentials', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676068, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005403', 'abnormal nerve conduction', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676069, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676070, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676071, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676072, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676073, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676074, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676075, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676076, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676077, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676078, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676079, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003468', 'increased single cell response intensity', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676080, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5714285714285714, 14.104646927382092, 2.838978380371773, 'UPHENO:0002259', 'abnormality of autonomic nervous system physiology'),
(676081, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676082, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676083, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003475', 'increased summary potential intensity', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676084, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000947', 'convulsive seizures', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676085, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003889', 'enhanced sensorimotor gating', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676086, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676087, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676088, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676089, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4666666666666667, 6.644251262574015, 1.7608664313914348, 'UPHENO:0005116', 'abnormal peripheral nervous system'),
(676090, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676091, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676092, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676093, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0021010', 'impaired synaptic physiology', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676094, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004859', 'abnormal synaptic plasticity', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676095, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676096, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676097, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676098, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676099, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012006', 'abnormal hippocampus physiology', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676100, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676101, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003467', 'abnormal single cell response intensity', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676102, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676103, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676104, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676105, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676106, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676107, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003473', 'decreased summary potential threshold', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676108, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0013806', 'encephalopathy', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676109, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676110, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003996', 'clonic seizures', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676111, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676112, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003480', 'increased nerve fiber response intensity', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676113, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676114, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0002064', 'seizures', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676115, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0003472', 'increased summary potential threshold', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676116, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676117, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676118, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676119, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676120, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676121, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.5333333333333333, 14.104646927382092, 2.742713685616938, 'UPHENO:0002259', 'abnormality of autonomic nervous system physiology'),
(676122, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0000948', 'nonconvulsive seizures', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(676123, 'HP:0005341', 'Autonomic bladder dysfunction', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
